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ABSTRACT
STUDY OF THE DNA DAMAGE COMPLEXES WITHIN THE HTLV-1 TAX
ONCOPROTEIN INTERACTOME
Sidi Mehdi Belgnaoui
Eastern Virginia Medical School and Old Dominion University, 2009
Director: Dr. O. John Semmes

Human T-cell leukemia virus type 1 (HTLV-1) is a transforming retrovirus that
can give rise to adult T-cell leukemia (ATL) and HTLV-1 associated myelopathy/tropical
spastic paraparesis (HAM/TSP). Tax is a virally encoded oncoprotein that is involved in
HTLV-1 mediated cellular transformation. It has been hypothesized that Tax induces
genomic instability via repression of the cellular DNA damage repair response. Our
laboratory has previously shown that the interaction between Tax and various proteins
involved in the DNA-damage response pathway impairs the ability of these proteins to
mount an efficient repair response. As part of these observations, we proposed that Tax
induces a constitutive phosphorylation state in the DNA-dependent Protein Kinase
(DNA-PK) which effectively saturates the naive response to new DNA damage events.
In this study, using Liquid Chromatography-Mass Spectrometry, we determined
that the mediator of DNA damage checkpoint protein 1 (MDC1) is also part of the Taxbound complex. MDC1 is a DNA damage repair (DDR) protein that is found in nuclear
foci called ionizing radiation-induced foci (IRIF) that form in response to DNA damage.
In this study we show that MDC1, which is a part DNA-PK-MDC1 signaling pathway, is
active in Tax expressing cells. In addition, we demonstrate that Tax recruits MDC1 to
"Tax speckled structures" (TSS). The same observation was made when the localization
of other DDR proteins such as DNA-PK were examined. These results suggest an ability

of Tax to generate a damage-independent DDR response. Here, we demonstrate that
MDC1 is recruited away from the TSS to the IRIF following damage, whereas DNA-PK
phosphorylated at threonine 2609, an activated form of DNA-PK, and BRCA1 were
shared between the two entities. These results suggest that there is a limited amount of
MDC1 in the cell that is competed for between TSS and IRIF. One potential impact of
generating a damage independent DDR response is competitive sequestering of
components of the DDR away from the actual sites of damage. This competitive
recruitment of cellular DDR may explain the observation that Tax expression results in
genomic instability.
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SECTION 1
INTRODUCTION

Retroviruses
The Retroviridae, or retroviruses, are RNA viruses that are capable of infecting
all vertebrates. Retroviruses are enveloped viruses that possess a single stranded RNA
genome, and replicate via a DNA intermediate. Each virion has two copies of the
genome. They may be divided into simple and complex retroviruses according to the
organization of their genomes. All retroviruses possess four virally encoded genes. These
are the gag gene, which encodes the virion structural proteins, the pol gene, which
encodes the various virion-associated enzymes (reverse transcriptase and integrase), the
env gene, which encodes the envelope glycoprotein, and the pro gene, which encodes the
virion protease. Simple retroviruses typically carry only this elementary information,
while complex retroviruses incorporate in their genomes some additional regulatory
genes (1). They are characterized by a very unique life cycle. Following the entry of the
virion into the host cell, the genomic RNA is reverse transcribed into DNA, which is then
incorporated into the host's genome. The integrated viral DNA is then called the
provirus, and it will be used as a template for the production of new viral RNAs and
proteins, ultimately leading to the formation of new virions. Immature virions, which are
characterized by the presence of unprocessed precursor proteins, are first released from
the infected cells. Maturation consists of the cleavage of these precursor proteins and
leads to a change in structure and morphology of the virion (2). The cleavage of Gag, Pol

The model journal for this dissertation is The Journal of Biological Chemistry.
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and Env precursor proteins eventually produces the proteins that will form the mature
infectious virion (Fig. 1). Processing of the Gag precursor will give rise to the matrix
protein (MA), the capsid protein (CA) and the nucleocapsid protein (NC). The cleavage
of the Pol precursor gives rise to PR for protease, RT for reverse transcriptase and IN for
integrase. Finally, processing of the Env precursor produces the surface protein (SU) and
the transmembrane protein (TM) (3). In addition to the viral proteins, each virion
contains two identical, positive-sense, single-stranded RNA molecules that are each 7 to
13 kilobases (kb). The last component of the virion is the envelope, which is a lipid
bilayer that has been acquired from the host plasma membrane during the budding
process.

Human T-Cell Leukemia Virus Type 1
Human T-Cell leukemia virus type 1 (HTLV-1) belongs to the family
Retroviridae and was the first human retrovirus to be discovered (4). The life cycle of
HTLV-1 is similar to that of other retroviruses. It starts with the interaction of the
envelope glycoprotein on the virion with specific host-cell membrane proteins. This
allows the viral envelope to fuse with the plasma membrane of the cell. The lipid
membrane of the virus incorporates in the cell's membrane and the core enters the host
cell. The core contains the viral genetic material as well as enzymes that participate in the
first stages of viral replication. The viral reverse transcriptase allows the conversion of
the viral RNA into double stranded DNA. The double stranded viral DNA then enters the
nucleus and is integrated into the host cell's chromosomal DNA by the viral integrase.
The provirus is then transcribed by the host cell RNA polymerase, generating mRNAs
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FIGURE 1. General structure of a retrovirus. Schematic representation of a
mature retrovirus

4

and genomic RNA molecules. The host-cell machinery translates the viral mRNAs into
virion proteins which assemble with genomic RNA to form progeny nucleocapsids. The
nucleocapsids interact with the membrane-bound viral glycoproteins and bud from the
host cell (1).
HTLV-I is a complex retrovirus and belongs to the delta-type retroviruses, which
also include bovine leukemia virus, human T-cell leukemia virus type II (HTLV-II), and
simian T-cell leukemia virus (5). In 1983, the virus was successfully cloned and the
complete sequence of the 9 kb proviral genome was resolved (6). In addition to two long
terminal repeats (LTRs), the HTLV-1 genome encodes gag,pol, and env genes, as well as
a unique region, designated pX (Fig. 2A). Therefore, instead of the LTR-gag-pol-envLTR genome organization of replication competent simple retroviruses, HTLV-1 has a
LTR-gag-pol-env-pX-LTR genomic structure (7). The pro gene spans the 3' part of the
gag region and the 5'part of the pol region, and a ribosomal frameshift is used to express
the protease as part of the Gag polyprotein precursor (8). The pX region can encode
multiple proteins using alternative open reading frames. These are the accessory proteins
pl2* expressed from ORF I, p l 3 u and p30 n from ORF II and the regulatory proteins Rex
and Tax from ORF III and ORF IV, respectively (9). The accessory proteins are not
essential for viral replication in vitro, but they appear to be crucial for viral persistence in
vivo (9). On the other hand, Tax and Rex regulatory proteins are known to be critical for
viral replication (9). The 27 kD Rex protein acts at the post-transcriptional level and
modulates gene expression. The 40 kD Tax protein is a strongfr-<ms,-activatorof viral
gene expression (10).
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FIGURE 2. The HTLV-1 genome. A, structure of the HTLV-1 genome. B,
feedback mechanism. Tax is spontaneously expressed from the doubly
spliced viral transcript (1), Tax activates viral transcription (2), Rex which is
expressed from the same mRNA as Tax inhibits splicing of viral RNA (3),
causing the accumulation of unspliced mRNAs, thus leading to expression of
Gag, Pol and Env proteins. This also induces a sharp decrease in Tax and
Rex expression.
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HTLV-1 has a unique mode of regulation of its viral replication (Fig. 25). First,
an initial HTLV-1 transcript is fully spliced into the pX region, thus leading to Tax and
Rex expression. Tax induces the ^vms-activation of the viral genome. This causes an
accumulation of Rex, which inhibits the splicing of the viral transcripts. Consequently,
unspliced gag-pol-env and env mRNAs are produced, leading to the expression of the
viral structural proteins. In addition, inhibition of viral RNA splicing causes a decrease in
fully spliced />XmRNA, resulting in a sharp decrease in Tax expression and ultimately to
a downregulation of viral gene expression. This feedback mechanism ensures efficient
viral gene expression at the initial stage of infection, and the subsequent decrease in gene
expression allows the virus to escape detection by the host immune system (7).

Cellular Tropism and Viral Entry
A variety of cell types can be infected by HTLV-1, such as T-lymphocytes, Blymphocytes, monocytes and fibroblasts (11).

It has been determined that glucose

transporter-1 (GLUT-1), which is a ubiquitous cell surface receptor, is a receptor for
HTLV-1 (12). HTLV-1 pro virus is mostly detected in CD4+ T lymphocytes and to a
lesser extent in CD8+ T cells (13). This might be explained by the fact that Tax causes an
increase in CD4+ T cell proliferation and inhibits apoptosis in those same cells (14). It is
believed that HLTV-1 spreads through cell-to-cell transmission. This hypothesis is
supported by the fact that no virions can be detected in the serum of HTLV-1-infected
individuals. Moreover, infectivity of infected cells is much higher than that of free virions
(15-17). In vitro studies have shown that HTLV-1-infected cells form "virological
synapses" with uninfected cells. These structures allow contact between infected and
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uninfected cells and cause the accumulation of the viral proteins Gag and Env as well as
viral RNA. Ultimately, this leads to the transfer of the virus to the uninfected cells
through the "virological synapses" (16).

Epidemiology
About 10 to 20 million people worldwide are currently infected with HTLV-1
(18). HTLV-I is endemic in southwestern Japan, the Caribbean islands, the areas
surrounding the Caribbean basin, and Central Africa. In addition, there are HTLV-I
carriers in South America, Papua New Guinea, and the Solomon Islands (19). Japan has
approximately 1.2 million individuals infected with HTLV-1 (20).
There are three major routes of HTLV-1 infection. The infection is spread
primarily from mothers to their children, most commonly through milk (21-25). HTLV-1
can also be transmitted sexually from infected men to women via virus-infected cells
present in semen (26, 27). Transmission from women to men is very rare (1). Parenteral
transmission is the third route of transmission (1). This mode of transmission accounts for
the high frequency of intravenous drug users that have become infected (28-33).

Diseases of HTLV-I Infection
HTLV-1 was the first retrovirus to be shown to cause a human cancer, adult Tcell leukemia (ATL) (19). HTLV-1 infection induces another incurable life threatening
disease

called

(HAM/TSP) (34).

HTLV-1-associated

myelopathy

and tropical

spastic

parapesis
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Adult T-cell leukemia
In the 1970s, adult T-cell Leukemia (ATL) was first described due to a
geographical clustering of leukemias in southwestern Japan (19). In 1980 and 1981,
human T-cell Leukemia virus was isolated and identified as the exclusive causal agent of
ATL (4). The link between ATL and HTLV-1 was established by showing the presence
of an antibody against HTLV-1 in sera from a patient with ATL and the finding of
proviral DNA in ATL cell lines (35, 36). Soon after infection, the virus goes into a latent
state, making the infected individuals asymptomatic seropositive carriers. About 5% of
these individuals develop one of the viral-associated diseases 10 to 40 years after
infection (37). In Japan, 800 to 1000 new ATL cases are diagnosed every year (20).
Despite intensive chemotherapy, aggressive ATL is a disease with a poor prognosis (38).
Study of the molecular pathogenesis of HTLV-1-mediated T-cell transformation is
crucial to improve ATL treatment regimen.
The viral Tax protein is considered to play a central role in the process leading to
ATL (37). It is thought that Tax causes transformation through various mechanisms
which include the induction of chromosomal instability and the abrogation of DNA repair
(20). ATL's mean age of onset of disease is 55 (39). There are four clinical subtypes of
ATL: acute, chronic, smoldering and lymphoma types. The subtypes are determined
according to the following criteria: the number of abnormal T cells in peripheral blood,
serum lactic acid dehydrogenase (LDH) level, tumor lesions in various organs, and
clinical course (40-42). Symptoms of the acute type of ATL, which represents 55% of all
cases, include general malaise, fever, cough, dyspnea, abdominal fullness, thirst,
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drowsiness, lymph node enlargement, hepatosplenomegaly and jaundice, as well as
abnormal laboratory findings such as marked leukocytosis, hypercalemia, high serum
levels of LDH, a soluble form of interleukin-2 receptor (IL-2R) a chain, and the presence
of distinctive leukemic cells with lobulated nuclei (39, 40, 43). Following onset of ATL,
combination chemotherapy often leads to transient remission of the disease. The median
survival time for patients diagnosed with the acute type of ATL is only 6.2 months (40).

HTLV-1 associated myelopathy/tropical spastic paraparesis and other diseases
HAM/TSP was first diagnosed in 1985 by two independent groups (44, 45).
HAM/TSP occurs in about 1 in 1646 HTLV-1-seropositive individuals, and the time
between HLTV-1 infection and the onset of the disease range from months to decades
(46). Developing both ATL and HAM/TSP at the same is a very rare occurrence.
Symptoms of HAM/TSP are spasticity of lower extremities, urinary bladder disturbance,
lower muscle weakness, and sensory disturbance with poorly defined thoracic sensory
levels (45). Furthermore, patients with HAM/TSP have HLTV-1 antibodies in the serum
and cerebrospinal fluid (CSF), a mild lymphocyte pleocytosis in CSF, and lymphocytes
with lobulated nuclei in the blood and/or CSF. The median survival time of patients who
develop HAM/TSP is about 10 years, and death is in general due to complications like
infections and cancers (44-46).
Other HTLV-1 associated diseases include HTLV-1 uveitis (HAU) and HTLV-1
associated arthropathy (HAAP) (47). Symptoms of HAU are blurred vision or
myodysopsia with acute or sub-acute onset, iritis, vitreous opacities, retinal vasculitis,
and retinal exudates and hemorrhages (48). In HAAP, HTLV-1 antibodies are detectable
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in synovial fluids of the affected joints and HLTV-1 proviral DNA is found in both
synovial tissue and in synovial fluid lymphocytes (49). Other diseases that have been
linked

to HTLV-1

infections

are polymyositis,

chronic respiratory

diseases,

lymphadenitis and dermatitis (47).

Diagnosis of HTLV-1 infection
Antibody screening is a commonly used method to diagnose HTLV-1 infection.
Commercial enzyme immunoassay (EIA) or particle agglutination assays are available to
detect HTLV-1 antibodies (50). When first introduced, EIAs generated a relatively high
number of false positive results (51). However, more recent EIAs that use recombinant
proteins and/ or synthetic HLTV-1 peptides have been much more reliable (52).
Nonetheless, it is still recommended to perform a confirmatory assay following EIAs in
order to discriminate between false positive and positive results (52). Confirmation tests
include indirect immunofluorescence assays and western blots (52, 53). One issue with
these confirmatory tests is that they cannot always distinguish between HTLV-1 and
HTLV-2 (54). The assay of choice for detection of HLTV-1 infection is PCR. These PCR
assays are often based on tax, which is the most conserved region of HTLV-1 (55, 56). In
addition, real-time PCR, which allows quantifying the proviral load, is frequently used as
a marker for prognosis and disease progression of infected people (57-61).

The Tax Oncoprotein
Tax is a viral oncoprotein that is crucial for the initial stages of viral mediatedtransformation of T-cell after HTLV-1 infection (20). Tax can bind the Tax-responsive
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element (TRE-1) in the viral long terminal repeats (LTRs) and trans-activate viral gene
expression (62). In parallel, Tax can also trans-activate a variety of cellular genes, which
leads to a variety of changes in the cell (62-66). Tax also interferes with cell function
through interactions with proteins involved in different cellular functions, such as DNA
damage repair and cell cycle (67). In the cell, Tax is mostly present in the nucleus and
forms what are called Tax speckled structures (TSS) (68). However, it should be noted
that a considerable portion of Tax is also present in the cytoplasm (69).

Transforming potential of Tax
The viral Tax protein is considered to play a crucial role in the process leading to
ATL (37). Many studies on the oncogenic potential of Tax in cultured cells and animal
models have been done. It was shown that Tax is able to induce neoplastic transformation
of the rat fibroblast cell line Rat-1 (70) and the mouse fibroblast NIH/3T3 line (71).
Furthermore, Tax can immortalize primary human T-cells derived from peripheral blood
or cord blood (72, 73). This has been shown by transducing cells with Tax expressed
from rhadinoviral (72) or retroviral (73) vectors. These results highlight the central role
of Tax in the transformation process.
Genomic instability is thought to play a crucial role in the process of
carcinogenesis (74). HTLV-1-transformed ATL cells show a variety of chromosomal
abnormalities including duplication, deletions, translocations, rearrangement and
aneuploidy (75). Due to the critical role of Tax in HTLV-1-induced oncogenesis, it is
believed that Tax has a detrimental effect on the integrity and stability of the cellular
genome. One proposed mechanism by which Tax induces genomic instability is the
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abrogation of DNA repair. The association between Tax and the presence of DNA
damage was first demonstrated using a micronucleus formation assay (76). It was shown
that Tax induces micronuclei formation, which represents fragmented chromosomes
indicative of DNA damage, or defects in DNA repair or in chromosomal segregation
(76). Additionally, gene amplification was used to determine the effect of Tax on
genomic stability. Gene amplification is a known indicator of genomic instability. It was
shown that that there was a five-fold increase in gene amplification in Tax-expressing
cells, which indicated that Tax expression contributes to genomic instability (77).
Together, these results show that Tax induces genomic instability; however, the precise
mechanism remains to be determined.
Tax affects a variety of cellular functions such as cell cycle regulation,
transcription and the DNA damage repair pathway (75). Tax-mediated transformation is
the result of its ability to both transcriptionally regulate cellular genes expression and to
functionally inactivate proteins involved in cell-cycle progression and DNA repair (75).
Tax oncogenic activity is accomplished through transcriptional activation and proteinprotein interaction with cell cycle regulators (75).

Tax is a viral and cellular trans-activator
Tax was initially discovered as a toms-activator of HTLV-1 gene expression (78).
Tax is able to trans-activate viral gene expression by trans-activating the viral long
terminal repeats (LTR). In addition, Tax can also trans-activate various cellular genes
through complex interaction with cyclic AMP-responsive element binding protein
(CREB), CREB-response elements (CRE), and transcriptional coactivators CREB-
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binding protein (CBP), p300 and P300/CBP-associated factor (PCAF) (62-66). Tax has
also been shown to activate transcription from a number of critical cellular genes through
the N F - K B pathway (79-81). Tax induces persistent activation of the N F - K B pathway by
directly binding and stimulating IKB kinase y (IKKy), which in turn phosphorylates IKB,
causing its degradation (79-81). The role of

IKB

but Tax causes its degradation, thus allowing

is to sequester

NF-KB

NF-KB

in the cytoplasm,

to enter the nucleus and cause the

activation of the N F - K B pathway.

Tax dysregulates the cell cycle
Tax-induced genomic instability is partly the result of cell cycle dysregulation.
Progression through cell cycle is a tightly controlled process which is crucial for proper
replication and chromosomal segregation (82). Impairment of these two mechanisms can
cause genomic instability. Tax affects the cell cycle through transcriptional activation and
direct interaction with cell cycle regulatory proteins (75). The effects of Tax on the cell
cycle lead to accelerated progression through Gl phase, coupled with defects in Gl/S, S,
G2/M and M checkpoints (83-87). Tax activates cyclin-dependent kinases (Cdks) such as
Cdk 4 and 6 through direct interaction which results in retinoblastoma (Rb) protein
hyperphosphorylation (88, 89). Once phosphorylated, Rb releases the E2F1 transcription
factor, leading to accelerated cell-cycle transition from Gl to S (90, 91). In addition, our
laboratory showed that Tax expression causes an accumulation of cells in G2/M, which
suggested that Tax abrogates the G2/M checkpoint (92). In fact, our laboratory also
established in the same study that Tax colocalizes and interacts with Chk2, causing its
activation which leads to the observed G2/M accumulation. These examples show that

14

Tax is able to dysregulate different stages of the cell cycle which ultimately can lead to
genomic instability.

Tax and the DNA repair machinery
Loss of genomic integrity through Tax is partly due to its effect on the cell cycle.
Tax also causes genomic instability through the impairment of the DNA damage repair
pathway. DNA damage repair is crucial to maintain the integrity of the genome. As cells
divide, DNA can be damaged by environmental factors or as a result of nucleotide
misincorporation during replication (75). A properly functioning DNA damage repair
pathway ensures that daughter cells do not inherit any mutations (75). DNA damage can
be repaired by different pathways such as nucleotide excision repair (NER), base excision
repair (BER), mismatch repair (MMR), and double strand break repair (75). The first link
between Tax and DNA repair was made when it was shown that Tax represses the
transcription of the human DNA polymerase p (pol (3) promoter (93), an enzyme
involved in BER and MMR (94). In addition, Tax has also been shown to suppress NER
(95), and this correlates with its ability to activate transcription of the proliferating cell
nuclear antigen (PCNA) (96, 97).
Our laboratory has previously shown that Tax interacts with and functionally
alters DNA-dependent Protein Kinase (DNA-PK) (98). The predominant DSB repair
pathway in mammalian cells is the non-homologous end joining (NHEJ) pathway, in
which broken DNA ends are rejoined. DNA-PK is the key enzyme in the NHEJ pathway
of DSB repair (99-102). We found that the kinase activity of DNA-PK is increased in the
presence of Tax (98). Furthermore, Tax induced hyperphosphorylation of DNA-PK at

15

S2056 and T2609, and co-localized with these phosphorylated forms in nuclear foci (98).
We also demonstrated that DNA-PK activity mediates Tax activation of Chk2 (98),
which is a known target of DNA-PK phosphorylation (103).
Another known target of DNA-PK is the histone protein H2AX. DNA damage
induces histone H2AX phosphorylation by ATM, ATR and DNA-PK (104).
Phosphorylated H2AX (termed y-H2AX) contributes to DNA double strand break repair.
The mechanism behind the role of y-H2AX in DNA repair is not yet fully understood, but
y-H2AX is thought to be a sensor of damage and recruiter of DNA damage repair
proteins (104). Another important aspect of y-H2AX, which is not yet fully understood,
is that it needs to be dephosphorylated once the repair has been completed (105, 106).
Our laboratory has shown that, in the presence of Tax alone, there is dramatic increase in
the level of y-H2AX compared to cells that do not express Tax (98). At first, it seems that
the presence of y-H2AX would stimulate DNA repair, but as mentioned earlier, for
proper repair y-H2AX needs to also be dephosphorylated. This suggests that by causing
persistent phosphorylation of H2AX, Tax does not allow the cell to detect and repair
newly formed damage.
MDC1 is another crucial protein involved in the repair of DNA double strand
breaks. In the studies described in this dissertation, we determined that Tax interacts with
the mediator of DNA damage checkpoint protein 1 (MDC1). Following DNA damage,
MDC1 binds directly to the phosphorylated form of H2AX at serine 139 and recruits
downstream DNA damage repair proteins to the damage sites such as 53BP1 and NBS1
which is part of the MRE11-RAD50-NBS1 (MRN) complex (107, 108). MDC1 also
recruits RNF8, a RJNG-finger ubiquitin ligase, which in turn ubiquitylates H2AX (109,
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110). This induces a change in chromatin conformation causing the DNA to "open up",
which allows the recruitment of downstream DNA damage repair proteins (109, 110). In
addition,

MDC1

knockdown

cells

display

a

shortened

duration

of

H2AX

phosphorylation, suggesting that it may protect H2AX from dephosphorylation (108).
Furthermore,

MDC1

directly

interacts

with

DNA-PK

and

regulates

its

autophosphorylation at T2609 in response to DNA damage (111). Another study on
MDC1 demonstrated that it not only binds Chk2 through the phosphorylated threonine 68
of Chk2, but this binding was shown to be essential for Chk2-mediated DNA damage
responses (112). Finally, the central role of MDC1 is illustrated by the fact that MDC1 -/mice demonstrate many phenotypes of H2AX -/- mice, including growth retardation,
male infertility, immune defects, chromosome instability, DNA repair and radiation
sensitivity (113). Tax interaction with such an essential protein of the DNA damage
repair pathway suggests that it may alter MDC1 's function, which could disrupt the entire
pathway. This may partially explain the mechanism by which Tax interferes with the
DNA damage repair machinery, which leads to genomic instability and cellular
transformation.

SECTION 2
SPECIFIC AIMS

Human T-cell leukemia virus type 1 (HTLV-1) is a human transforming
retrovirus. HTLV-1 is the causative agent of adult T-cell leukemia (ATL), and a
neurodegenerative disease, HTLV-1 associated myelopathy/tropical spastic paraperesis
(HAM/TSP) (19, 34). Research has shown that expression of the viral oncoprotein Tax
alone can cause cellular transformation (114). Tax is a potent /rara-activating protein of
viral and cellular genes (62-66, 78). The mechanism behind Tax's oncogenic activity is
not fully understood, but it is has been established that Tax directly interacts with many
cellular proteins which affects various cellular processes (67).
One major characteristic of HTLV-1 transformed cells is genomic instability. It is
thought to be a direct effect of Tax and an essential process for cellular transformation.
Our laboratory has shown the interaction between Tax and various DNA damage repair
(DDR) proteins such as Chk2 and DNA-PK (92, 98). These proteins interact with Tax in
discrete nuclear foci called "Tax speckled structures" (TSS) (68, 115). In a normal cell,
following DNA damage, DDR proteins get recruited to the DNA damage sites called
ionizing radiation-induced nuclear foci (IRIF) (104). TSS and IRIF seem to share several
proteins. One of these proteins is a DNA repair enzyme, DNA dependent protein kinase
(DNA-PK) (98). It has been demonstrated that Tax induces DNA-PK activation which in
turn causes phosphorylation of H2AX histone protein (called y-H2AX) (98). Similarly,
following DNA damage, DNA-PK gets recruited to the IRIF and phosphorylates H2AX
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which induces a change in chromatin conformation allowing the recruitment of more
DDR proteins (116, 117). This indicates that Tax mimics the DNA Damage repair
pathway which may contribute to its dysregulation. Preliminary data have shown the
presence of MDC1 (mediator of DNA damage checkpoint protein 1), another protein
involved in the DNA damage response pathway, in the Tax interactome. Our study is the
first one to directly link Tax and MDC1. MDC1 regulates various aspects of DNA
damage response pathways and interacts with many proteins involved that same pathway
such as DNA-PK and BRCA1 (107, 111, 112, 118, 119).MDC1 is crucial for IR-induced
autophosphorylation of DNA-PK, which is important for H2AX phosphorylation and
subsequent DNA damage repair (111). Additional evidence of the importance of MDC1
in H2AX phosphorylation is illustrated by the fact that the loss of MDC1 expression or
the decrease of its cellular levels by short interfering RNA (siRNA) treatments leads to
the reduction of H2AX phosphorylation in response to IR (107, 108, 113). MDC1 is also
involved in the Chk2-mediated DNA damage response (112). MDC1 was found not only
to bind Chk2 through the phosphorylated Thr68 of Chk2, but this binding was also shown
to be essential for Chk2-mediated DNA damage responses (112). As mentioned earlier,
MDC1 seems to play an important role in phosphorylation of H2AX, but in addition, it
has also been demonstrated that MDC1 is crucial for H2AX ubiquitylation (109). H2AX
ubiquitylation, though not as studied and known as H2AX phoshorylation, is a crucial
step in the DNA damage repair mechanism (110). Knowing that MDC1 is present in the
Tax interactome and that it has a central role in the DNA damage response pathway
through its interaction with DNA-PK, Chk2 and H2AX, we will focus in this dissertation
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on the role of MDC1 in the Tax induced dysregulation of the DNA damage response
pathway.
Analysis of the functional and physical interactions of Tax can advance our
understanding of the mechanism behind Tax-induced genomic instability. The objective
of this proposal was to investigate the structural and functional characteristics of the
DNA damage complexes within the Tax interactome. The hypothesis of the research was
that Tax interacts with and functionally alters cellular proteins involved in the DNA
damage response pathway. This study should make a significant contribution to our
understanding of how Tax transforms cells.
The objective of this proposal was accomplished by pursuing the following
specific aims:
AIM 1. Characterization of Tax-containing protein complexes involved in the DNA
damafie response.
To establish the different cellular process that are influenced by Tax, it is essential
to determine the various proteins that are part of the Tax interactome. We will isolate Tax
using a transient expression model followed by purification of Tax complexes. The
components of the Tax complexes will be characterized using mass spectrometry.
AIM 2. Structural characterization of MDC1 within the Tax complexes.
We will determine whether Tax interacts with MDC1. We will also look at the
localization of both Tax and MDC1 within the cell. Since Tax is a //vms-activator, we
will determine whether it has an effect on MDC1 expression. We will investigate the
effect of Tax on known downstream targets of MDC1 such ubiquitylated y-H2AX. Next,
we will determine the effect of knocking down MDC1 in Tax-expressing cells. In
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addition, studies of the structural modification of MDC1 will also be conducted in the
presence or absence of Tax and DNA damage.
AIM 3. Determine the functional significance of the interaction of Tax with MDC1.
We will measure DNA damage in the presence of Tax after treatment with
ionizing radiation (IR) and determine whether Tax impairs DNA repair. We will examine
the biological consequence of the Tax-MDCl interaction as it relates to genomic
instability. We will also determine the localization of MDC1 and other DDR proteins in
the Tax expressing cells in the presence of DNA damage.
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SECTION 3
CHARACTERIZATION OF TAX-CONTAINING PROTEIN COMPLEXES
INVOLVED IN THE DNA DAMAGE RESPONSE

Introduction
Human T cell leukemia virus-1 (HTLV-1) is the etiological agent of adult T-cell
Leukemia

(ATL) and HTLV-associated

myelopathy/tropical

spastic

paraperisis

(HAM/TSP) (19, 34). Tax, which is one of the HLTV-1 encoded proteins, plays a central
role in viral transcription and cellular transformation (20, 114, 120, 121). All of these
functions are carried out through a variety of protein-protein interactions. Tax was first
discovered as a viral trans-activator (78). It is also known that Tax is a trans-activator for
many cellular genes (122). In fact, Tax is able to deregulate expression of more than one
hundred genes (122). Therefore, it is not surprising that Tax interacts with many
transcriptional activators, basal transcription factors and proteins involved in chromatin
remodeling (67). Briefly, the mechanism by which Tax trans-activates viral and cellular
genes is as follows. In the viral genome, Tax alleviates transcriptional repression of the
long terminal repeat (LTR) by directly interacting with histone deacetylases (HDAC1)
and/or methyltransferases (HMT) (123-125). Next, Tax recruits via binding cAMPresponsive element/activating transcription factors (CREB/ATF), transcription factors,
histone modifying enzymes and chromatin remodelers (SWI/SNF, P/CAF and CBP/p300)
(67). Ultimately, this causes changes in the chromatin conformation, leading to the
recruitment of basal transcription factors to the TATA box (67). In addition, Tax binds to
the transcription factor IIA (TFnA), transcription factor IID (TFnD) and the TATA
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binding protein (TBP) which stabilizes the initiation complex (126-128). This is followed
by the recruitment by Tax of the positive transcription elongation factor b (P-TEFb)
causing stimulation of elongation through the phosphorylation of the carboxy-terminal
domain (CTD) of the RNA polymerase II (129). Furthermore, Tax also binds to
SWI/SNF, which prevents stalling of transcription elongation (67, 130).
In addition to interacting with transcription factors and post-transcriptional
regulators, it is also known that Tax binds a variety of proteins involved in cellular
signaling (67).

NF-KB

signaling is one of the pathways that Tax influences via protein-

protein interactions. There are two alternative

NF-KB

signaling pathways: the canonical

and the non-canonical and both are stimulated by Tax (131-133). In the canonical
pathway, Tax binds both IKB kinase y/NF-icB essential modulator (IKKy/NEMO) in the
cytoplasm (80, 81). Tax also interacts and activates MAPK/ERK kinase kinase 1
(MEKK1) and TGF-p activating kinase 1 (TAK1) (134, 135). This leads to IKKcc and
IKKp phosphorylation which in turn phosphorylate IKB, causing its proteosomal
degradation (80, 81). Once degraded,
then recruited to

KB

IKB

releases the NF-KB dimer, p50/RelA, which is

enhancers in the nucleus, ultimately leading to constant

NF-KB

activity (67). In the non-canonical pathway, Tax binds both IKKa and pi00, causing
pi00 phosphorylation and subsequent ubiquitylation, allowing nuclear translocation of
the p52/RelB dimer to the nucleus leading to NF-KB activation (131, 133).
Other signaling pathways affected by Tax through protein-protein interaction
include JNK, AP-1 and TGF-P (67). In the JNK pathway, Tax binds G-protein pathway
suppressor 2 (GPS2) which is an inhibitor of the JNK signaling. This leads to the
inhibition of GPS-2 mediated inactivation of JNK signaling causing persistent activation
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of the JNK pathway (136). In the AP-1 pathway, Tax binds and activates the
phosphatidylinositol 3-kinase (PI3K) which in turn phosphorylates the Akt effector at
serine 473 triggering the activation of AP-1 and cell proliferation (137). Finally, in the
TGF-P signaling pathway, Tax interacts with Smad2, Smad3 and Smad4 (138). This
ultimately leads to the inhibition of Smad3-Smad4 binding to TGF-P target genes thus
inhibiting the induction of apoptosis by TGF-P (138, 139).
Lastly, Tax interacts with proteins involved in cell cycle and DNA damage repair
(67). Tax can bind cyclin Dl, cyclin D2, cyclin D3, CDK4 and CDK6 (88, 89, 140, 141).
Tax interacts with and stabilizes the cyclinD2/CDK4 complex which then phosphorylates
the retinoblastoma protein (Rb) (67). Tax also binds Rb directly and targets it for
proteosomal degradation (142). E2F is then released by Rb which leads to an acceleration
of Gl/S transition (67). Finally, as mentioned earlier, Tax also interacts with proteins
involved in the DNA damage repair pathway such as Rad51 (130), DNA topoisomerase 1
(143), Chk2 (92) and DNA-PK (98). Protein-protein interaction of DNA damage repair
proteins with Tax can lead to the dysregulation of the DNA damage repair pathway. For
instance, our laboratory determined that Tax not only binds DNA-PK but that it also
causes its hyperphosphorylation at S2056 and T2609 (98). This leads to H2AX
phosphorylation (termed y-H2AX) which is an early double strand break marker. In Tax
expressing cells, H2AX is maintained in a hyperphosphorylated state which interferes
with the detection of new DNA breaks and the proper repair of these breaks (98). This
process might contribute the Tax induced genomic instability.
The few examples mentioned above show that Tax interacts with numerous
cellular proteins thus influencing various cellular processes such as transcription, cell
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cycle regulation, DNA repair, and apoptosis (75, 130). It is clear that there are many
more proteins present in the Tax interactome and identification of these Tax-binding
proteins can give valuable information on the different pathways affected by Tax and on
the mechanisms involved. The objective for this aim is to construct the Tax interactome.
We accomplished this objective using the following experimental approaches. (1) We
expressed and isolated Tax on beads; (2) We incubated the Tax isolate on beads with
nuclear extracts in order to allow interaction of Tax with nuclear proteins; (3) We used
mass spectrometry to identify proteins that interact with Tax. Using this approach, we
found known Tax binding proteins (such as DNA-PK) and novel Tax binding proteins
such as MDC1. We also found proteins involved in a variety of cellular pathways such as
cell cycle, DNA damage repair and apoptosis. We attempted to classify the proteins
according to their function in the cell.

Experimental Procedures
Cell culture and transient transfection
293T cells were maintained at 37°C in a humidified atmosphere of 5% CO2 in air,
in Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine serum
(Cambrex, East Rutherford, NJ) and 1% penicillin-streptomycin (Invitrogen, Carlsbad,
CA).
Transfections of 293 T cells were performed by standard calcium phosphate
precipitation. Cells were plated at lxlO 5 cells/ml. The following day, plasmid DNA in
2M CaCl2 and 2X HBS were added dropwise to cells in fresh medium. Cells were
incubated at 37°C overnight and fresh medium was added. The cells were harvested 48 h
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post-transfection, following a single wash with IX PBS, in 500 ul M-Per mammalian
protein extraction reagent (Pierce, Rockford, IL) with protease inhibitor cocktail (Roche,
Palo Alto, CA) and immediately frozen at -80°C.

Plasmids
Generation of the STaxGFP and SGFP plasmids have been described earlier
(144). Briefly, the S-tagged expression vectors STaxGFP and SGFP were constructed by
inserting the tax-EGFP fusion or EGFP ORF, respectively, into the Smal site of pTriEx4Neo (Novagen, Madison, WI) in frame with the amino-terminal S-tag and His-tag.
HPX Tax expression vector and H2AX-GFP vector were also used for the
immunoprecipitation experiments. The H2AX-GFP vector was a gift from Dr. Tomilin
(UC Davis School of Medicine, CA, USA).

Immunoblot analysis
Proteins separated by electrophoresis were transferred

to Immobilon-P

membranes (Millipore, Billerica, MA) using the semidry transfer method with 20 V
applied for 1 hour. The membranes were then blocked for 1 hour at room temperature in
lx Odyssey blocking buffer (Li-Cor Biosciences, Lincoln, NE). Primary antibodies
diluted in lx Odyssey blocking buffer were applied to the membranes and allowed to
interact at 4°C overnight on an orbital shaker. Membranes were washed four times for 5
minutes with PBS-1% Tween. Li-Cor Odyssey secondary antibodies were diluted to a
concentration of 1/20,000 in lx Odyssey blocking buffer containing 0.5% SDS and 0.5%
Tween and then incubated for 1 hour at room temperature on an orbital shaker in the dark.
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The membranes were washed four times for 5 minutes with PBS-1% Tween and then
stored in PBS and in the dark until ready to be analyzed. Blots were scanned and
analyzed with a Li-Cor Odyssey scanner and software (Li-Cor Biosciences, Lincoln, NE).

Antibodies
For immunofluorescence analysis the following antibodies were used: anti-IFI16
goat polyclonal (1/100, Santa Cruz Biotechnology, Santa Cruz, CA) and anti-MCM7
(1/100, Santa Cruz Biotechnology, Santa Cruz, CA). For immunoblot analysis, anti-GFP
mouse monoclonal (1/500, Santa Cruz Biotechnology, Santa Cruz, CA) and anti-Tubulin
mouse monoclonal (1/2000, Sigma, St. Louis, MO) were used.

Immunofluorescence
Cells that were plated on a coverslip were washed twice with ice cold PBS. Cells
were then fixed with 4% paraformaldehyde for 12 minutes at room temperature. Next,
cells were washed 3 times with PBS. Methanol was added and left on the cells for 2
minutes. Cells were washed 4 times with PBS. The primary antibody was diluted in 3%
Bovine Serum Albumin (BSA) in PBS at the appropriate concentration. A 100 ul drop of
the diluted primary antibody was then placed on parafilm in a wet chamber. The
coverslip was then inverted onto the drop and left incubating at 4°C overnight. The next
day, the coverslip was removed from the parafilm and placed back into the tissue culture
dish. The cells were washed twice with PBS-1% Tween 20 and twice with PBS. Nuclei
were counterstained with To-Pro-3 iodide (Invitrogen, Carlsbad, CA) diluted 1/1,000 in
the 3% BSA in PBS by putting a 100 ul drop of the solution onto parafilm in a wet
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chamber. The coverslip was inverted onto the drop and left incubating for 1 hour at room
temperature in the dark. Next, the coverslip was put back into a tissue culture dish and
washed twice with 3% BSA in PBS then twice with PBS. One drop of Vectashield
mounting medium with DAPI (Vector Laboratories Inc, Burlingame, CA) was placed
onto a slide. The coverslip was inverted onto the slide and left to air dry for one hour at
room temperature in the dark. The coverslip was then sealed to the slide using nail polish.
Confocal fluorescent images were acquired using a Zeiss LSM 510 confocal microscope
at 63X magnification with a 2X zoom using Argon (488 nm), HeNel (543 nm), and
HeNe2 (633 nm) lasers, and imaged with LSM Image Browser software (Carl Zeiss,
Jena, Germany).

S-tag protein purification
Prepared cell lysate (750 ul) was incubated with 90 ul of 50% slurry of S -protein
agarose (Novagen, Madison, WI) for 30 minutes rotating at room temperature, then
washed 3 times with 1 ml Bind/Wash Buffer (20 mM Tris-HCl pH 7.5, 150 raM NaCl,
0.1% TritonX-100) by centrifugation at 4°C for 5 minutes each time at 500 g (2500 rpm).
The washed beads were either eluted by resuspension in 45 ul Laemmli Sample Buffer
(Bio-Rad, Hercules, CA) with P-mercaptoethanol, followed by boiling for 10 minutes or
kept for incubation with Jurkat nuclear lysates. Beads that were eluted were then
separated by electrophoresis in a 4%- to 12%-gradient sodium dodecyl sulfate (SDS)
polyacrylamide gel. Following electrophoresis, the gel was stained with Biosafe™
Coomassie (Bio-Rad, Hercules, CA). Briefly, the gel was washed three times with sterile
water for 5 minutes each, and then it was covered with Biosafe™ Coomassie and left
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shaking for one hour. The gel was then washed twice with sterile water for 30 minutes
each. The picture of the gel was then captured using Li-Cor Odyssey scanner and
software (Li-Cor Biosciences, Lincoln, NE).

Tax bead nuclear lysate pull down
Freshly prepared STaxGFP/SGFP beads (200 ul) were thoroughly washed 3 times
with 500 ul of ice cold incubation Buffer (IB; 25 mM HEPES, ph 6.5, 150 mM NaCl, 1%
NP-40, 10 mM MgCl2, 1 mM EDTA, 1% glycerol). The samples were spun at 5000 rpm
at 4°C for each wash. After the final wash, enough IB was added to make a 50 % slurry.
The resulting slurry was stored one ice. Next, the commercially available Jurkat nuclear
lysate (Active motif, cat# 30614, 200 ug) was pre-cleared. To do so, 50 ul of unreacted
S-beads were washed 3 times with ice cold incubation buffer. S-beads slurry (5 ul) was
added to 25 ug of Jurkat nuclear lysate and incubated for 30 minutes at 4°C with mild
shaking. The beads were centrifuged at 2000 g (5000 rpm) for 1 minute at 4°C and the
supernatant was transferred to a fresh tube and 10 ul of STaxGFP or SGFP beads
prepared earlier was added. The volume was brought to 50 ul with IB. Samples were then
incubated for 60 minutes at 4°C with mild shaking. Next, the beads were centrifuged at
2000 g (5000 rpm) at 4°C for 3 minutes and the supernatant was carefully removed. Ice
cold PBS (250 ul) was added and the beads resuspended by briefly vortexing. Samples
were spun at 2000 g (5000 rpm) for 3 minutes at 4°C and the supernatant was discarded.
The two last steps were repeated four more times. For LC-MS analysis, the supernatant
was removed and 50 ul of 6.25 ug/ul of trypsin solution was added and left to incubate
for 3 hours at 37°C.
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In-Bead trypsin digestion and LC-MS/MS analysis
Beads were incubated with 50 ul of 6.25 ug/ul of trypsin solution and left to
incubate for 3 hours at 37°C. The samples were then spun down at 2000 g (5000 rpm) for
5 minutes at 4°C. The supernatant was transferred to a new microcentrifuge tube and
vortexed and dried using a vacuum concentrator. The sample was stored at -20°C until
ready to use. For LC-MS/MS analysis the sample was resuspended in 11 ul of 5%
Acetonitrile, 0.1% Formic acid and 0.005% Heptafluorobutyric acid (HFBA). Analysis
was performed on a thermoElectron LTQ Linear Ion Trap tandem mass spectrometer.
Protein identity was determined by sequence analysis with TurboSEQUEST™
(ThermoFinnigan, San Jose, CA) or MASCOT (Matrix Sciences, London GB) using an
indexed viral subset database of the non-redundant protein database from National Center
for Biotechnology Information (NCBI) web site (http://www.ncbi.nlm.nih.gov/).

Immunoprecipitation
Whole cell lysates (1500 ug in 1000 ul volume) from Mock transfected cells,
cells transfected with HPX and H2AX-GFP vectors, HPX alone or H2AX-GFP alone
were incubated with 15 ul anti-tax pep 3 rabbit polyclonal antibody at 4°C for 4 hours,
with constant rotation. The lysate were then incubated with 90 ul Protein A/G plus
Agarose beads (Zymed, San Francisco, CA) while rotating for overnight at 4°C. The
beads were washed 3 times with 1 ml of IX SNNTE buffer (5% sucrose, 500 mM NaCl,
1% Nonidet P-40, 50 mM Tris-HCl [pH 7.4], 5 mM EDTA) by centrifugation at 4°C for
5 minutes each time at 500 g (2500 rpm). Proteins were eluted from beads by
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resuspension in 45 fj.1 Laemmli sample buffer (Bio-Rad, Hercules, CA) with Pmercaptoethanol, and boiled for 10 minutes. The samples were the centrifuged at 4°C for
5 minutes at 500 g (2500 rpm) and the supernatant was transferred to a sterile eppendorf
tube. The samples were either ran in a gel directly or frozen at -20°C.

Results
Efficient expression and purification ofSTaxGFP and SGFP
To identify the different proteins in the Tax interactome, we first needed to
efficiently express Tax in mammalian cells. We decided to use the STaxGFP plasmid
(Fig. 3A), which was previously described (144), for two main reasons. First, it has an
amino-terminal S tag that allows protein isolation using the S-Tag purification system
(Novagen), which is based on the interaction between a 15-amino acid S tag and S
protein immobilized on agarose beads, both of which are derived from RNase S (145).
Second, it also has a carboxy-terminal GFP tag which permits the monitoring of protein
localization and transfection efficiency. Furthermore, it was previously shown that the
STaxGFP plasmid expresses biological active full-length Tax protein (144). S-tagged
GFP (SGFP) was our control plasmid (Fig. 3A). We chose to use human embryonic
kidney 293 T (293 T) cells because of their high transfection efficiency. We transiently
transfected both plasmids into 293 T cells and determined expression levels of each
protein by Western blotting and immunohistochemistry analysis. For Western blot
analysis, a GFP antibody was used to detect both STaxGFP and SGFP. This permitted the
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FIGURE 3. Efficient expression of STaxGFP. A, schematic representation of
the plasmid used. B, cell lysates from 293T cells transiently transfected with
STaxGFP and SGFP were subjected to SDS-PAGE and analysis by
immunoblotting by the indicated antibodies. C, confocal microscopy images of
an STaxGFP cell and an SGFP cell. Images are magnified x63 with a x4
zoom.
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direct comparison of the amounts of both proteins in the cells. As shown in Fig. 35, we
could express both proteins at similar levels. Next, we wanted to determine the
transfection efficiency of our plasmid. Using immunofluorescence, we determined that
we could approximately transfect STaxGFP in 75% of the cells in one plate. Furthermore,
STaxGFP formed the appropriate "Tax Speckled Structures" (TSS) (Fig. 3C), which is
characteristic of the biologically active full-length Tax protein (68). SGFP was efficiently
transfected in about 85% of the cells and, as expected, the protein was localized in both
the nucleus and the cytoplasm (Fig. 3Q.
Next, we purified the protein using the S-Tag purification system. Cells lysates
from 293 T cells transiently expressing STaxGFP or SGFP were incubated with S protein
immobilized on agarose beads. Fig. 4 shows that after affinity tag purification and
stringent washes we isolated both STaxGFP and SGFP.

Identification of the proteins present in the Tax inter actome
In order to identify the different proteins in the Tax interactome, we designed an
experiment in which we tried to eliminate as many variables as possible (Fig. 5). First, we
isolated both STaxGFP and SGFP from transiently transfected 293 T cells. Next, we
stringently washed the beads in order to only have the S-tagged protein bound to the Sbeads. Next, we incubated the S-tagged protein bound to the S-beads with a specific
amount of commercially available pre-cleared Jurkat nuclear extract. HTLV-1 infects T
cells, and Jurkat cells are an immortalized line of T lymphocytes, therefore it is
appropriate to use Jurkat nuclear extract to identify Tax binding proteins. Furthermore, by
only leaving the S-tagged proteins on the beads and incubating them with a
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FIGURE 4. Efficient purification of STaxGFP. Whole cell lysate from 1000
ng of total protein in STaxGFP transfected cell or 400 |ag of protein in SGFP
transfected cells were pulled down by S-beads (120 \i\), incubated O/N at 4°C.
The beads pellet were washed by RIPA buffer for 3 times thoroughly.
Approximately, 60 p.l sample buffer were loaded on a 4-12% SDS-PAGE
following boiling the beads. The gel (1.5 mm thick) were stained by Bio-Safe
Coomassie Blue (Bio Rad) for 1 hr at RT.
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FIGURE 5. Construction of the Tax interactome
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predetermined amount of proteins, we eliminated several variables. For instance, Tax
trans-activates a variety of cellular genes and this might cause a dramatic increase in
certain proteins in STaxGFP transfected cells compared to SGFP expressing cells, thus
increasing potential unspecific binding. Using Jurkat nuclear extract from non-Tax
expressing cells ensures that we have the same amount of each nuclear protein incubating
with STaxGFP and SGFP. Therefore, if a protein is found to bind STaxGFP but not
SGFP, we would be sure that it is due to an actual binding and not nonspecific binding
caused by the increased amount of that protein in Tax expressing cells. Beads were then
subject to trypsin digestion. Liquid chromatography-Mass spectrometry (LC-MS/MS)
analysis was then performed. We selected the proteins that had at least two peptides hits,
an expect score below 0.5 and an individual peptide score indicating at least homology.
The experiment was performed three different times. Next, we generated a list in which
the proteins were identified in all three experiments. Also, we generated the same list
with the SGFP control and subtracted proteins that were found in the SGFP control from
the list of the STaxGFP experiment. Repeating the experiment three times resulted in the
elimination a large number of proteins from our final list. In fact, 406 proteins were
found in a least one experiment, 315 were found in at least two experiments and only 76
proteins were presents in all 3 experiments. Proteins in the one out of three and two of
three lists might still bind Tax, but we had higher confidence that the 76 proteins found in
three out of three lists were indeed in the Tax interactome (see "Appendix A" for the list).

Classification of the Tax binding proteins according to their functions
Not surprisingly, we found in the Tax interactome, proteins that were already
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• RNA Splicing
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• Immune
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FIGURE 6. Proteomic analysis of the Tax interactome. Proteomic analysis
showed the presence in the Tax interactome of a number of proteins involved
in DNA repair such as DNA-PK, Chk2, H2A and MDC1.
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known to bind Tax and that our laboratory studied extensively, such as DNA-PK and
Chk2. DNA-PK was in the three out of three list whereas Chk2 was in the two out of
three list. These two proteins are involved in the DNA damage repair pathway, and our
laboratory previously showed that Tax causes the aberrant activation of both of these
proteins in the absence of DNA damage. This causes the dysregulation of the DNA
damage repair machinery that ultimately might lead to genomic instability (92, 98, 146).
Due to the presence of Chk2, which is a known Tax binding protein, in the two out of
three list, we decided to include these proteins in our classification of Tax binding
proteins according to their cellular functions (Fig. 6). Many categories were created such
as cell cycle, transcription and apoptosis. Next, we determined through literature search
which proteins were studied in relation to Tax. In addition to DNA-PK and Chk2, we
found other known Tax binding proteins such as the E3 SUMO- protein ligase Ranbinding protein 2 (RanBP2) (147), the Retinoblastoma protein (Rb) (142), the nuclear
pore glycoprotein p62 (148) and SWI/SNF (130).
Additionally, we found several proteins that were not previously linked to Tax.
For instance, both the interferon gamma-inducible protein 16 (IFI-16), a protein involved
in p53 dependent apoptosis (149), and the minichromosome maintenance deficient
protein 7 (MCM7), a protein implicated in DNA replication (150), were never reported to
bind to Tax and both were present in three out of three list of the Tax interactome. Many
Tax binding proteins have been reported to interact with Tax in the TSS (68, 115). This
was determined by immunofluorescence studies showing colocalization of these proteins
with Tax. Here, we looked at the localization of MCM7 and IFI16 in Tax expressing cells
and determined that they both colocalized with Tax suggesting that it may be interesting
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to pursue the relationships of Tax and these two proteins (Fig. 7).
Another new Tax binding protein we found in the three out of three list is the
mediator of DNA damage checkpoint protein 1 (MDC1) (Fig. 8). MDC1 relates to both
DNA-PK and Chk2. As a result of its ability to regulate several aspects of DNA damage
response pathways. It is crucial for DNA-PK autophosphorylation and H2AX
phosphorylation (107, 108, 111, 113). In addition to its role in H2AX phosphorylation, it
has been shown that MDC1 is essential for H2AX and H2A ubiquitylation. H2AX and
H2A ubiquitylation, which is a critical step in the DNA damage repair mechanism, is part
of the chromatin remodeling process which "opens up" the DNA at the damage sites thus
allowing the recruitment of more DNA damage repair proteins (110). It should be noted
that several H2A subtypes were identified in our analysis of the Tax interactome.
Therefore, we sought to determine whether Tax and H2AX interact. Overexpression of
GFP tagged H2AX in Tax expressing cells, followed by immunoprecipitation confirmed
that Tax and H2AX indeed interact (Fig. 9). This further strengthens the hypothesis that
Tax forms a complex with several members of the DNA damage machinery.
In the LC-MS/MS analyses, MDC1 was identified by 6 unique peptides
with significant MS/MS Mascot ion scores, expect scores and a sequence coverage of
4.7%. The low coverage is due to the large size of the protein which has 2,089 amino
acids and molecular mass of about 226 kD (Fig. 8). Fig. 10 shows the MS/MS spectrum
of a triply charged peptide with an m/z of 716.68 that identifies the MDC1 sequence
HLAPPPLLSPLLPSIKPTVR from amino acid 1060 to 1079 with a molecular mass of
2147.04 Da. The high quality of the spectrum is illustrated by the presence of high
number of both b and y ions. In the y ion series, the most intense peak is the yl7
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FIGURE 7. Colocalization of Tax and novel Tax binding proteins. STaxGFP
was expressed in 293 FT cells. Endogenous MCM7 (A) and IFI116 (fi) were
detected with the indicated antibodies; Tax expression was detected via the
GFP fusion. Nuclei were visualized by co-staining with TO-PRO-3 iodide. Three
images were merged to visualized overlap. Confocal microscopy images are
magnified x63 with a x4 zoom.
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FIGURE 8. MDC1 unique peptides. In the LC-MS/MS analysis of the Tax
interactome, MDC1 was identified by 6 unique peptides.
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FIGURE 9. H2AX co-purifies with Tax. Cell lysates from 293T cells
transiently co-transfected with H2AX-GFP and Tax, or transfected with H2AXGFP alone or Tax alone or Mock transfected were (A) subjected to SDSPAGE and analysis by immunoblotting by the indicated antibodies or (6)
immunoprecipitated with anti-Tax antibody as described under "Experimental
Procedures" and subjected to SDS-PAGE and analysis by immunoblotting with
the indicated antibody.
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FIGURE 10. MDC1 peptide with sequence HLAPPPLLSPLLPSIKPTVR. A,
representative MS/MS fragmentation and the b and y ion annotation of a triply
charged MDC1 peptide with sequence HLAPPPLLSPLLPSIKPTVR. S, table
showing the y and b ions. Note the dominating high intensity proline y17 ion.

43

proline consistent with the high ionization efficiency and thus intensity of a proline
containing fragment. This further validates the identification of the peptide sequence. The
same observation is made in Fig. 11, in which the most intense peak of the MS/MS
spectrum of the peptide TPETVVPTAPELQISTSTDQPVTPKPTSR from amino acid
1608 to 1636 is again a proline (y23). Fig. 12 is an example of doubly charged peptide
with an m/z of 898.94 that identifies the sequence VGLPLLSPEFLLTGVLK from amino
acid 2055 to 2071 with almost complete annotation of the b and y ions series including
the proline (ylO).
In addition, the exponentially modified protein abundance index (emPAi) score of
MDC1, which indicates the relative amount of a protein in the mixture, was 0.13 (Fig. 8)
and it is comparable to the emPAi scores of DNA-PK (0.27) and Chk2 (0.25). Both
DNA-PK and Chk2 are known to bind Tax (92, 98) thus increasing our confidence that
MDC1 is indeed present in the Tax interactome.

Discussion
We attempted to construct the Tax interactome using a specific experimental
design that would decrease variability and false positives. First, we efficiently expressed
STaxGFP and SGFP in mammalian cells. We then used the S-Tag purification system
(Novagen) to pull down both STaxGFP and SGFP. After showing that we could
successfully express and pull down both STaxGFP and SGFP, we then washed the beads
stringently in order to only keep the S-tagged proteins bound to beads. We then incubated
the beads with a predetermined amount of pre-cleared Jurkat nuclear extract. This step
accomplished several goals. First, we could control the amount of proteins mixed with
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the S-tagged proteins. We tried the experiment using several concentrations of nuclear
extract and determined the optimal amount for LC-MS/MS analysis. Second, Jurkat cells
are T cells therefore they are more biologically relevant to this study than 293 T cells
which are derived from kidney cells. Using non-Tax transfected cells would eliminate
bias due to Tax upregulation of cellular genes. Each protein found to bind Tax using our
experimental design should be present at the same concentration in every Jurkat nuclear
extract. This increases our confidence that a Tax-binding protein hit is really present in
the Tax interactome and that it is not just a result of increased nonspecific binding due to
increased expression. The experiment was repeated three separate times, and after LCMS/MS analysis, we ended up with one list for each experiment. We eliminated the
proteins found in the SGFP list and only chose in our final list the proteins that were
found in at least two experiments. The higher the number of experiments a protein was
found in, the more confident we were in the presence of that protein in the Tax
interactome. Therefore, proteins that were found in all three experiments were considered
the likeliest to interact with Tax. However, this does not mean that the proteins that were
detected only once or twice do not bind Tax. In fact, we found proteins that were
previously shown to bind Tax in the two of three list such as Chk2. For this reason, we
decided to include in our final list, proteins from the two out of three list and the three out
of three list.
Proteins in the final list could be classified in many different cellular processes
such as cell cycle regulation, apoptosis and DNA replication. As expected, we found in
the final list proteins that were already known to bind Tax such as DNA-PK. This was a
good indicator that our experiment worked properly. Other interesting proteins that were
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not known to bind Tax were also identified such as IFI16 and MCM7. One interesting
protein that was identified in the Tax interactome is the mediator of DNA damage
checkpoint protein 1 (MDC1). MDC1 interacts with numerous proteins involved in the
checkpoint signaling and DNA damage repair pathway. Furthermore, following DNA
damage MDC1 gets phosphorylated and translocates to DNA damage sites where it
allows recruitment and accumulation of downstream DNA damage repair proteins (104).
Our laboratory has been studying the relationship between Tax and other proteins
involved in DNA damage repair such as DNA-PK, Chk2 and y-H2AX (92, 98, 146). Our
laboratory previously showed that Tax binds and activates DNA-PK causing
phosphorylation of the H2AX histone protein (98). In a normal cell, H2AX
phosphorylation by DNA-PK only occurs after induction of DNA damage, but in the
presence of Tax, H2AX is constitutively hyperphosphorylated which does not allow the
cell to detect newly formed damage. MDC1 is a crucial part of this process since it binds
DNA-PK and seems to be important in the process of H2AX phosphorylation (111). In
addition, MDC1 was also found to bind Chk2, which is another Tax binding protein,
and is essential for Chk2-mediated DNA damage responses (112).
In this study, we designed an experiment that allowed us to identify with high
confidence proteins that are present in the Tax interactome. We have identified new Taxbinding proteins, and their relationship to Tax should be studied further in the future.
However, due to the identification of MDC1 in the Tax interactome and its central role in
the DNA damage response pathway through its interaction with DNA-PK, Chk2 and
H2AX, we decided to focus on the role of MDC1 in the Tax induced dysregulation of the
DNA damage response pathway (92, 98, 146).
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SECTION 4
STRUCTURAL CHARACTERIZATION OF MDC1 WITHIN THE TAX
COMPLEXES

Introduction
Human T-cell leukemia virus-1 (HTLV-1) is a human transforming retrovirus
which can cause adult T-cell Leukemia (ATL) and HTLV associated myelopathy/tropical
spastic paraperisis (HAM/TSP) (19, 34). Tax is one of the HLTV-1 encoded proteins and
plays an essential role in viral transcription as well as cellular transformation leading to
ATL (20, 37, 114, 120, 121). The oncogenic potential of Tax is demonstrated by the fact
it can induce neoplastic transformation of the rat fibroblast Rat-1 cell line (70) and the
mouse fibroblast NIH/3T3 cell line (71). Furthermore, Tax expression immortalizes
primary human T-cells (72, 151). Finally, expressing Tax in vivo induces tumors in
transgenic mice (120, 152, 153). Tax induces cellular transformation by transcriptionally
regulating cellular gene expression and also by functionally inactivating proteins
involved in cell-cycle progression and DNA repair (75).
Impairment of the DNA damage repair by Tax greatly contributes to genomic
instability (77). In a normal cell, the DNA damage repair pathway is essential to maintain
the integrity of the genome. As cells divide, DNA can be damaged due to nucleotide
misincorporation during replication or by environmental factors (75). Proper repair of
damaged DNA ensures that mutations are not passed on to daughter cells. DNA damage
can be repaired by several pathways such as base excision repair (BER), nucleotide
excision repair (NER), mismatch repair (MMR), and double strand break (DSB) repair
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(75). Examples of Tax interacting proteins involved in the DNA damage repair pathway
are Rad51 (130), DNA topoisomerase 1 (143),Chk2 (92) and DNA-PK (98).
Previous studies from our laboratory investigated the relationship between Tax
and DNA-PK (98). DNA-PK is a key enzyme in non-homologous end joining (NHEJ),
the predominant DSB repair pathway in mammalian cells (99-102). We found that Tax
not only binds DNA-PK, but that it induces DNA-PK hyperphosphorylation at S2056 and
T2609, thus activating it. This leads to the activation of downstream targets of DNA-PK
such as Chk2 and H2AX (98). Phosphorylation of H2AX (termed y-H2AX) is an early
event in the sensing of newly formed DNA damage and it causes changes in the
chromatin conformation. This allows the recruitment of downstream DNA damage
response (DDR) proteins either directly by y-H2AX or by other repair proteins to the
DNA damage sites, also called ionizing radiation-induced nuclear foci (IRIF) (104). Once
the damage is repaired, y-H2AX needs to be dephosphorylated in order to maintain the
DNA damage repair machinery properly functioning (105, 106). Our laboratory has
shown that there is dramatic increase in the level of y-H2AX in Tax expressing cells
compared to cells that do not express Tax (98). The constant H2AX phosphorylation in
Tax expressing cells, taken together with the importance of y-H2AX dephosphorylation
in properly functioning DNA damage repair machinery, suggests that Tax interferes with
the DNA damage repair machinery by not allowing the cell to detect and repair newly
formed damage.
After isolation of the Tax complex from the cells and

identification of the

different Tax interacting proteins using liquid chromatography tandem mass spectrometry
(LC-MS/MS), we identified a novel Tax-binding protein, mediator of DNA damage
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checkpoint 1 (MDC1), a key enzyme in the DNA damage response pathway (104).
MDC1 is a large protein (about 250 kD) that possesses two consecutive BRCA1 Cterminal (BRCT) motifs (118) and an N-terminal forkhead-associated (FHA) domain
(107, 111, 118, 154-157). FHA domains are phosphoprotein binding domains usually
found in signaling proteins (158); BRCT domains are also very common in many DNA
damage repair proteins (159, 160). In addition, tandem BRCT (tBRCT) domains
constitute phosphoprotein binding domains (159-161). It has been shown that MDC1
binds to phosphorylated histone H2AX near sites of DNA double-stranded breaks
through its tBRCT motif, thus facilitating the recruitment of other DNA damage repair
proteins to DNA damage foci (108). The MRE11-RAD50-NBS1 (MRN) complex,
which is crucial for DNA damage repair, is recruited by MDC1 via the binding of the
phosphorylated Ser-Asp-Thr (SDT) repeats of MDC1 to the N-terminal FHA domain of
NBS1 (162, 163). The phosphorylation of the SDT repeats of MDC1 is mediated by
casein kinase 2 (CK2) (163, 164). MDC1 is also essential for the accumulation of other
DDR proteins within IRIF including BRCA1, 53BP1 and Chk2 (107, 112, 118, 119,
165). Another important role of MDC1 in response to DNA damage is the recruitment of
RNF8, a RTNG-fmger ubiquitin ligase, which in turn ubiquitylates H2AX (109).
Ubiquitylation of H2AX causes changes in chromatin conformation at the DNA damage
sites, thus "opening up" the DNA, similar to phoshorylation, allowing the recruitment of
even more DDR proteins (109). Finally, DNA-PK also interacts with MDC1, and it was
shown that MDC1 is crucial for DNA-PK autophosphorylation at T2609 in response to
DNA damage (111).

52

Due to the presence of MDC1 in the Tax interactome and its central role in the
DNA damage response pathway through its interaction with DNA-PK, Chk2 and H2AX,
we focused on the role of MDC1 in the Tax induced dysregulation of the DNA damage
response pathway. Once we confirmed the interaction between Tax and MDC1, it was
important to determine the nature and the potential roles of that interaction. The Objective
of this aim is to confirm and characterize the physical interaction between Tax and
MDC1. We accomplished this objective using the following experimental approaches.
(1) We confirmed binding using S-pull down assay and immunoblotting techniques; (2)
Since Tax is a cellular transcriptional frvms-activator we determined the effect of Tax on
MDC1 expression levels in the cell; (3) We used immunohistochemistry technique to
determine the localization of Tax and MDC1; (4) We knocked down MDC1 expression
in Tax expressing cells using siRNA and looked at the effect on MDC1 downstream
targets; (4) We also conducted structural studies on MDC1 and examined its
phosphorylation pattern in Tax expressing cells since it is known that active MDC1 is
hyperphosphorylated (163, 164).

Experimental Procedures
Cell culture and transient transfection
293T cells were maintained at 37°C in a humidified atmosphere of 5% CO2 in air,
in Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine serum
(Cambrex, East Rutherford, NJ) and 1% penicillin-streptomycin (Invitrogen, Carlsbad,
CA).
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Transfections of 293T cells were performed by standard calcium phosphate
precipitation. Cells were plated at lxlO 5 cells/ml. The following day, plasmid DNA in
2M CaCl2 and 2X HBS were added dropwise to cells in fresh medium. Cells were
incubated at 37°C overnight and fresh medium was added. The cells were harvested 48 h
post-transfection, following a single wash with IX PBS, in 500 ul M-Per mammalian
protein extraction reagent (Pierce, Rockford, IL) with protease inhibitor cocktail (Roche,
Palo Alto, CA) and immediately frozen at -80°C.

Plasmids
Generation of the STaxGFP, STax and SGFP plasmids have been described
earlier (144). Briefly, the S-tagged expression vectors STaxGFP, STax and SGFP were
constructed by inserting the tax-EGFP fusion or EGFP ORF, respectively, into the Smal
site of pTriEx4-Neo (Novagen, Madison, WI) in frame with the amino-terminal S-tag and
His-tag.
i£4-tagged human MDC1 (pcDNA3-neo) was a gift from D. Lukas (Danish
Cancer Society, Copenhagen, Denmark).

SiRNA transfection
Cells were plated at 2x105 cells/ml in 60 mm plates and left to grow overnight.
The following day medium was changed with serum free and antibiotic free media 1 hour
prior to transfection. A total of 2 jag of STaxGFP or pTHEx4-Neo (empty vector) and 100
pmol of siRNA MDCI (Santa Cruz biotechnology inc. sc-43917) or siRNA control were
diluted in 500 ul of Opti-MEM® I medium without serum. Next, lipofectamin™ 2000 was
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gently mixed then 5 ul was diluted in 500 pi of Opti-MEM® I medium without serum in a
separate tube. The mixture was mixed gently and incubated for 5 minutes at room
temperature. After 5 minutes incubation, the diluted DNA and siRNA molecule were
mixed with the diluted Lipofectamin™ 2000. The solution was mixed gently and
incubated for 20 minutes at room temperature to allow complex formation to occur. The
DNA-siRNA-lipofectamin™ 2000 complexes were then added to the plate. We then
mixed gently by rocking the plate back and forth. We incubated the cells at 37°C in a CO2
incubator for 6 hours. The media was replaced with media that had serum and antibiotic.
Cells were left to grow for 48 hours and harvested.

Immunofluorescence
Cells that were plated on a coverslip were washed twice with ice cold PBS. Cells
were then fixed with 4% paraformaldehyde for 12 minutes at room temperature. Next,
cells were washed 3 times with PBS. Methanol was added and left on the cells for 2
minutes. Cells were washed 4 times with PBS. The primary antibody was diluted in 3%
Bovine Serum Albumin (BSA) in PBS at the appropriate concentration. A 100 ul drop of
the diluted primary antibody was then placed on parafilm in a wet chamber. The
coverslip was then inverted onto the drop and left incubating at 4°C overnight. The next
day, the coverslip was removed from the parafilm and placed back into the tissue culture
dish. The cells were washed twice with PBS-1% Tween 20 and twice with PBS. The
species-appropriate Alexa Fluor 594-conjugated secondary antibody (Molecular Probes)
was diluted at 1/1000 in 3% BSA in PBS. Nuclei were counterstained with To-Pro-3
iodide (Molecular Probes) diluted 1/1,000 in the same BSA-PBS and secondary antibody

55

solution. A 100 ul drop of BSA-PBS solution containing both the secondary antibody and
To-Pro-3 was placed onto parafilm in a wet chamber. The coverslip was inverted onto the
drop and left incubating for 1 hour at room temperature in the dark. Next, the coverslip
was put back into a tissue culture dish and washed twice with 3% BSA in PBS then twice
with PBS. One drop of Vectashield mounting medium with DAPI (Vector Laboratories
Inc, Burlingame, CA) was placed onto a slide. The coverslip was inverted onto the slide
and left to air dry for one hour at room temperature in the dark. The coverslip was then
sealed to the slide using nail polish. Confocal fluorescent images were acquired using a
Zeiss LSM 510 confocal microscope at 63X magnification with a 2X zoom using Argon
(488 nm), HeNel (543 nm), and HeNe2 (633 nm) lasers, and imaged with LSM Image
Browser software (Carl Zeiss, Jena, Germany).

Immunoprecipitation
Whole cell lysate (1500 ug) in 1000 ul volume was incubated with 15 ul anti-HA
rabbit polyclonal antibody (0.25 mg/ml, 71-5500, Zymed, San Francisco, CA) at 4°C for
4 hours, with constant rotation. The lysate was then incubated with 90 ul Protein A/G
plus Agarose beads (Zymed, San Francisco, CA) while rotating for overnight at 4°C. The
beads were washed 3 times with 1 ml of wash buffer (0.2 M NaCl, 0.5% Nonidet P-40,
20 mM Tris-HCl [pH 8.0], 1 mM EDTA) and pelleted by centrifugation at 4°C for 5
minutes each time at 500 g (2500 rpm). Proteins were eluted from beads by resuspension
in 45 ul Laemmli sample buffer (Bio-Rad, Hercules, CA) with (3-mercaptoethanol, and
boiled for 10 minutes. The sample was the centrifuged at 4°C for 5 minutes at 500 g
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(2500 rpm) and the supernatant was transferred to a sterile microcentrifuge tube. The
sample was either ran in a gel directly or frozen at -20°C.

Immunoblot analysis
Proteins separated by electrophoresis were transferred

to Immobilon-P

membranes (Millipore, Billerica, MA) using the semidry transfer method with 20 V
applied for 1 hour. The membranes were then blocked for 1 hour at room temperature in
lx Odyssey blocking buffer (Li-Cor Biosciences, Lincoln, NE). Primary antibodies
diluted in lx Odyssey blocking buffer were applied to the membranes and allowed to
interact at 4°C overnight on an orbital shaker. Membranes were washed four times for 5
minutes with PBS-1% Tween. Li-Cor Odyssey secondary antibodies were diluted to a
concentration of 1/20,000 in lx Odyssey blocking buffer containing 0.5% SDS and 0.5%
Tween and then incubated for 1 hour at room temperature on an orbital shaker protected
from light. The membranes were washed four times for 5 minutes with PBS-1% Tween
and then stored in PBS and in the dark until ready to be analyzed. Blots were scanned and
analyzed with a Li-Cor Odyssey scanner and software (Li-Cor Biosciences, Lincoln, NE).

Antibodies
For the immunofluorescence analysis, anti-MDCl goat polyclonal (1/100, Santa
Cruz Biotechnology, Santa Cruz, CA) was used to detect the localization of MDC1. For
immunoblot analysis, the following antibodies were used: anti-MDCl goat polyclonal
(1/200, Santa Cruz Biotechnology, Santa Cruz, CA), anti-GFP mouse monoclonal (1/500,
Santa Cruz Biotechnology, Santa Cruz, CA), anti-HA rabbit polyclonal (1/1500, Zymed,
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San Francisco, CA) , anti-Tubulin mouse monoclonal (1/2000, Sigma, St. Louis, MO),
anti-Tax-pep3 rabbit polyclonal (1/2000), anti-ORC2 rabbit polyclonal (1/400, Santa
Cruz Biotechnology,

Santa Cruz, CA), anti-y-H2AX (1/2000, R&D systems,

Minneapolis, MN).

Chromatin fractionation
Before harvest, the cells were rinsed twice with ice cold PBS. A total of 5x106
cells were harvested in 1.5 ml eppendorf tube using a cell scraper with cold PBS (1 ml).
The cells were then spun at 1500rpm for 2 minutes and the supernatant was discarded.
The cell pellet was washed with cold PBS and spun down at 1500 rpm for 2 minutes. The
cell pellet was then resuspended in 200 ul of buffer A (100 mM HEPES, pH 7.9, 10 mM
KC1, 1.5 mM MgCl2, 0.34 M Sucrose, 10% glycerol, 10 mM NaF, 1 mM Na 2 V0 3 , 1 mM
DTT and protease inhibitor cocktail) with a blunt 1000 ul tip. Triton X-100 was added to
a final concentration of 0.1%. The solution was mixed well and incubated on ice for 5
minutes. The tube was then centrifuged at 1,300 g (4000 rpm) at 4°C for 5 minutes. The
supernatant (fraction SI) was separated from the pellet (fraction PI) which contains the
nuclei. The fraction SI was clarified by high speed centrifugation at 20,000 g (14,000
rpm) at 4°C for 5 minutes. The supernatant (fraction S2), which represents the cytosolic
fraction, was collected and the pellet P2 was discarded. Fraction S2 was stored at -80°C
until ready to use. Pellet PI was washed once with buffer A (0.6 ml per tube) by
centrifugation again at 4000 rpm at 4°C for 5 minutes. Pellet PI was resuspended in 100
ul of buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, protease inhibitor cocktail)
with blunt 1000 ul tip and lysed for 30 minutes on ice. The sample was then centrifuged
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at 1,700 g (5000 rpm) at 4°C for 5 minutes. The supernatant (fraction S3), which contains
the soluble nuclear proteins, was separated from the pellet (fraction P2) which contains
the chromatin. S3 was stored at -80°C until ready to use. Fraction P2 was washed once
with Buffer B (0.6 ml per tube) and the pellet was collected after centrifugation at 10,000
g (11,000 rpm) at 4°C for 1 minute. Fraction P2 was then resuspended in M-PER
(Mammalian protein extraction reagent) protein extraction buffer (180 ul per sample)
which was followed by a short sonication. Fraction P2 was clarified by high-speed
centrifugation at 20,000 g (14,000 rpm) at 4°C for 5 minutes. The supernatant (fraction
P3), which contains the chromatin bound proteins, was collected and kept at -80°C until
ready to use.

Trypsin in-gel digestion and LC-MS/MS analysis
Coomassie blue stained protein band was excised with a scalpel on a glass plate.
The band was transferred to a 0.5 ml polypropylene eppendorf tube and the excess water
was removed. The band was briefly washed with 100 ul solution A (50 mM NH4HCO3,
pH 8.0) to make sure that the piece is at the correct pH. The gel piece was then incubated
with 200 ul of solution B (50 mM NH4HCO3/50% acetonitrile) for 10 minutes. The liquid
was removed and the same step was repeated twice. The liquid was removed and the gel
piece was incubated for 5 minutes in solution C (100 % acetonitrile). Solution C was
removed and evaporated briefly for 5 minutes in a vacuum concentrator. Next, the gel
piece was covered with 10 mM DTT in 50 mM NH4HCO3. The proteins were reduced for
45 minutes at 56°C in the thermocycler. The sample was cooled to room temperature and
the DTT was removed and 50 ul of 55 mM iodoacetamide in 50 mM NH4HCO3 was
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added and left to incubate for 45 minutes in the dark at room temperature. Iodoacetamide
was the removed and the gel piece was washed with 100 ul of solution A for 5 minutes
with shaking and then washed twice with 100 ul of solution B for 5 minutes. Next, the
gel piece was dehydrated with 100 ul solution C. The remaining liquid was removed and
the sample was dried in a vacuum concentrator. The gel piece was rehydrated in an ice
bath for 30 minutes with 50 ul of 12 ug/ul of trypsin in solution D (50 mM
NH4HCO3/10% acetonitrile). This was done to get as much active trypsin absorbed by the
gel piece as possible before the digestion started. Trypsin was carefully removed and 50
ul of solution D was added to the gel piece. The gel piece was digested overnight at 37°C.
The next day, the digest solution supernatant was transferred into a clean 0.5 ml tube. 50
ul of solution E (50% Acetonitrile/0.1% formic acid) was added to the gel piece and the
tube was centrifuged at room temperature at 8000 g (10,000 rpm) for 1 minute followed
by static incubation for 5 minutes. This was repeated twice. The supernatant was then
removed and combined with the initial digest solution supernatant. The extracted digest
was then vortexed and placed in a speed vacuum until dry. The sample was stored at 20°C until ready to use. For LC-MS/MS analysis the sample was resuspended in 11 ul of
5% acetonitrile, 0.1% formic acid and 0.005% heptafluorobutyric acid (HFBA). LC-ESIMS-MS analyses of MDC1 tryptic peptides were done on a linear trap quadrupole (LTQ)
mass spectrometer (Thermo Finnigan, Waltham, MA). The acquired MS/MS data was
submitted to an in-house Mascot daemon search engine (www.matrixscience.com) for
searches against the human protein sequences in the SwissProt database for protein and
post translational modification identification. The following parameters were used in the
searches: carbamidomefhylation of cysteines as a fixed modification; oxidation of
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methionines, deamidation of asparagines and glutamine, phosphorylation of serine,
threonine and tyrosine as variable modifications.

Results
Tax interacts with MDC1
Our goal was to identify the different cellular proteins within the Tax interactome
in vivo using the previously described STaxGFP vector which expresses the biologically
active full length Tax protein with an amino-terminal S-tag and a carboxy-terminal green
fluorescent protein (GFP). The S-Tag allowed purification of the protein, and GFP
facilitated monitoring of protein expression and localization. After purification of the Tax
protein followed by incubation with Jurkat nuclear extract, the bound proteins were
subjected to on-bead trypsin digest and LC-MS/MS analysis. The same experiment was
done using the SGFP vector as a control. Proteins that were known to bind Tax were
found in the Tax interactome such as DNA-PK and Chk2. One new protein that found in
the Tax interactome is the mediator of DNA damage checkpoint 1 (MDC1) protein.
We next sought to confirm that Tax interacts with MDC1 by pulling down Tax
using the S-tax purification system. Detecting endogenous MDC1 in the whole cell lysate
using the available antibodies is difficult. Therefore, we decided to overexpress both
MDC1 and Tax to confirm their interaction. HA-MDC1 was co-transfected with
STaxGFP into 293 T cells and we determined that we could efficiently co-express Tax
and MDC1 (Fig. 13). Next, Tax complexes were isolated from whole cell lysates with Sagarose beads and an immunoblot with anti-HA antibody revealed that MDC1 is present
in the Tax complex. When SGFP was co-expressed with FLA-MDC1 and pulled down
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HA-MDC1 (250 Kd)
STaxGFP (70 kd)
Tubulin (50 kd)

Anti HA
Anti-GFP
Anti Tubulin

FIGURE 13 . Efficient co-expression of STaxGFP and HA-MDC1. Cell
lysates from 293T cells transiently mock transfected or co-transfected with HAMDC1 and STaxGFP were subjected to SDS-PAGE and analysis by
immunoblotting by the indicated antibodies
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using S-agarose beads, we could not detect MDC1 which indicated the specificity of the
Tax-MDCl interaction (Fig. 14). In the same experiment, in addition to STaxGFP, we
also pulled down STax to assay whether the GFP tag was interfering with the MDC1
interaction, which was not the case.
Next, we looked at the localization of endogenous MDC1 in the cell in the
presence of Tax. Previous studies have shown that Tax forms discrete nuclear foci termed
"Tax speckled structures" (TSS) (68, 115). TSS overlap with interchromatin granules and
contain various proteins such as transcription factor

NF-KB

(115), spliceosome

component 35 (SC35) (68, 115) and DNA damage factors 53BP1 (92), Chk2 (92) and
DNA-PK (98). The proximity between Tax and cellular machineries involved in splicing,
transcription, checkpoint activation and DNA damage repair support the concept that Tax
interferes with these different pathways (92). Immunofluorescence analysis of MDC1 in
Tax expressing cells determined that it colocalizes with Tax in the TSS (Fig. 15). This
result, together with pull down experiment, indicates that Tax binds MDC1 and
specifically co-localizes with it at discrete nuclear foci.

Tax recruits MDC1 to the chromatin in absence of DNA damage
Tax can also £ra«,s-activate various cellular genes through complex interaction
with cyclic AMP-responsive element binding protein (CREB), CREB-response elements
(CRE), and transcriptional coactivators CREB-binding protein (CBP), p300 and
P300/CBP-associated factor (PCAF) (62-66). It has been shown that Tax is able to
deregulate the expression of more than one hundred genes (122). Therefore, we sought to
determine its effect on MDC1 expression using Western blot analysis. Our immunoblot
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FIGURE 14. Tax co-purifies with MDC1. Cell lysates from 293T cells
transiently co-transfected with HA-MDC1 and SGFP, STaxGFP or STax
(indicated) were (A) subjected to SDS-PAGE and analysis by immunoblotting
by the indicated antibodies or (S) affinity purified on S-protein agarose beads
as described under "Experimental Procedures" and subjected to SDS-PAGE
and analysis by immunoblotting with the indicated antibody

64

TO-PRO

MDC1

overlap
Tax

FIGURE 15. Colocalization of Tax and MDC1. STaxGFP was expressed in
293 FT cells. Endogenous MDC1 was detected with anti-MDC1 antibody (red,
1/200, rabbit, Santa Cruz); Tax expression was detected via the GFP fusion.
Nuclei were visualized by co-staining with TO-PRO-3 iodide . Three images
were merged to visualized overlap. Confocal microscopy images are
magnified x63 with a x4 zoom.
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experiments indicate that overall MDC1 protein expression was unaffected by Tax (Fig.
16A). It should be noted that multiple isoforms of MDC1 were detected. In addition, our
laboratory previously showed that in the absence of DNA damage, Tax recruits both
hyperphosphorylated DNA-PK and Chk2 to the chromatin (98, 146). Similarly, upon
DNA damage, DDR proteins, such as phosphorylated DNA-PK, accumulate at the site of
damage and, consequently, their levels increase in the cellular chromatin faction (119,
166-168). Recruitment of active DNA-PK to the chromatin by either Tax or in response
to DNA damage leads to an increase in H2AX phosphorylation (98). MDC1 is another
DDR protein that was reported to increase in the chromatin fraction following DNA
damage (169). However, the effect of Tax on the level of MDC1 in the chromatin bound
fraction has not been yet investigated. Immunoblot analysis of chromatin bound fractions
indicated that MDC1 is increased in the chromatin in Tax expressing cells (Fig. \6B).
This result correlates with our previous findings which suggested that Tax induces
constitutive signaling of the DNA-PK pathway thus causing the impairment of the
cellular response to new damage (98).

Activation ofMDCl by Tax
In the DNA-PK pathway MDC1 is a downstream target of DNA-PK. Previously,
our laboratory determined that Tax recruits DNA-PK phosphorylated at Ser-2056 and
Thr-2609 to the TSS suggesting that DNA-PK is active (98). Furthermore, an in vitro
kinase assay for DNA-PK using p53 peptide as a substrate, a known target of DNA-PK,
showed an increase in DNA-PK activity in the presence of Tax (98). Taken together,
these results showed that Tax recruited active DNA-PK to the TSS. Similarly, we
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FIGURE 16. Tax recruits MDC1 to the chromatin. A, cell lysates from 293T
cells transiently transfected with Tax or MOCK transfected were subjected to
SDS-PAGE and analysis by immunoblotting by the indicated antibodies . B,
chromatin fractions from 293T cells transiently transfected with Tax or Mock
transfected were subjected to SDS-PAGE and analysis by immunoblotting by
the indicated antibodies .
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attempted to determine the activation state of the MDC1 recruited to the TSS. One simple
way to determine whether MDC1 is active is to look at the level of the monoubiquity lated form of y-H2AX (mono-ub-y-H2AX) (109). In a normal cell following
DNA damage, activated MDC1 recruits RNF8, a RING-finger ubiquitin ligase, which in
turn ubiquitylates H2AX (Fig. 17^4). This causes a change in chromatin conformation,
thus "opening up" the DNA and allowing the recruitment of downstream DDR proteins
(109). Earlier studies have been able to detect mono-ub-y-H2AX using y-H2AX
antibodies in immunoblot experiments. The mono-ub-y-H2AX band appeared at 25 kD,
which is about 9 kD (the size of one ubiquitin) above the 16.5 kD y-H2AX band (170,
171). Therefore, using a y-H2AX antibody in an immunoblot analysis of chromatin
fractions, we attempted to detect mono-ub-y-H2AX. In the presence of Tax alone, we saw
an increase in y-H2AX at 16.5 kD as well as an increase in intensity of a 25 kD band
which corresponds to mono-ub-y-H2AX (Fig. 17C). These results suggest that, in Tax
expressing cells, active MDC1 recruits RNF8, leading to ubiquitylation of y-H2AX.
In order to make sure that MDC1 activation is responsible for ubiquitylation of yH2AX, we conducted a siRNA experiment in which we knocked down MDC1
expression. Immunoblot analysis of whole cell lysates showed that we could efficiently
knock down MDC1 (Fig. 175). When looking at the chromatin fractions, we determined
that siRNA to MDC1 did not change the levels of chromatin-bound MDC1 in non-Tax
expressing cells which can be explained by the already low amount of MDC1 in the
chromatin (Fig. 17Q. On the other hand, we saw a decrease in chromatin-bound MDC1
in Tax expressing cells following siRNA MDC1 treatment, confirming that MDC1
expression was knocked down (Fig. 17Q. In parallel, we also showed a decrease in the
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FIGURE 17. MDC1 is activated in Tax expressing cells. A, a schematic
representation of the DNA-PK-MDC1 signaling pathway following DNA
damage. B, siRNA control or SiRNA MDC1 was co-transfected with Tax in 293
T cells. Whole cell lysates were extracted and subjected to SDS-PAGE and
analysis by immunoblotting by the indicated antibodies. C, siRNA control or
SiRNA MDC1 was co-transfected with Tax in 293 T cells. Chromatin fractions
were extracted as described under "Experimental Procedures" and were
subjected to SDS-PAGE and analysis by immunoblotting by the indicated
antibodies
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Level of mono-ub-y-H2AX in cells co-transfected with Tax and siRNA against MDC1,
thus demonstrating that MDC1 is active in Tax expressing cells (Fig. 17C).

Phosphorylation analysis ofMDCl
Following DNA damage, MDC1 is phosphorylated. Phospo-peptide mapping of
MDC1 has not been done thoroughly due to the size and complexity of the protein (163).
However, a few phosphorylation sites have been identified in MDC1 following DNA
damage (172) and we wanted to determine whether Tax induced phosphorylation of any
of these sites. In this experiment, we overexpressed and immunoprecipitated HA-MDC1
in Tax expressing cells and non-Tax expressing cells, in the presence and absence of
ionizing radiation (Fig. 18). Following excision and tryptic digestion of the HA-MDC1
bands, LC-ESI-MS-MS analyses of MDC1 tryptic peptides was done on a linear trap
quadrupole (LTQ) mass spectrometer (Thermo Finnigan, Waltham, MA). The results
show that MDC1 is phosphorylated at several sites in the presence of Tax alone. These
sites are S-372, S-780, T-579, S-793, T-1157 and S-1175. S-372 is a site that was
previously reported to be phosphorylated in MDC1 following ionizing radiation (172).
Fig. 19 shows an example of a MS/MS spectrum of a phosphorylated peptide with a
dominant neutral loss peak of a H3PO4 group from the +3 parent ion. The search
identifies the MDC1 peptide IFHGVGTRGPGAPGLAHLQESQAGSDTDVEEGKAPQ
AVPLEK phosphorylated at S-372. This result suggests that MDC1 is activated in Taxexpressing cells. It should be noted that there are 216 possible phosphorylation sites in
MDC1 and earlier studies have unsuccessfully

attempted to do a complete

phosphopeptide mapping of the protein (163). This has been a challenge due to the
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FIGURE 18. HA-MDC1 immunoprecipitation. Whole cell lysatesfrom cells
transfected with HA-MDC1 or HA-MDC1 and Tax treated with 10 Gy or no
ionizing radiation were immunoprecipitated with anti-HA rabbit as described
under "Experimental Procedures". Samples were loaded on a 4-12% SDSPAGE. The gel (1.5 mm thick) were stained by Bio-Safe Coomassie Blue (Bio
Rad) for 1 hr at RT.
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complexity of the protein and the high number of phosphorylation sites. Phosphorylation
of MDC1 at S-372 is yet another indication that it is active in the Tax expressing cells,
but a more extensive phosphorylation analysis needs to be done to confirm the observed
phosphorylation sites.

Discussion
Cellular transformation caused by the HTLV-1 Tax oncoprotein is partly achieved
by the induction of genomic instability. One piece of evidence of Tax induced genomic
instability is the fact that the presence of Tax alone leads to micronuclei formation, which
represents fragmented chromosomes indicative of DNA damage, or defects in DNA
repair or in chromosomal segregation (76). Maintenance of the integrity of the genome
depends greatly on a properly functioning DNA damage repair pathway. During the cell
cycle, DNA can be damaged by various sources, such as environmental factors, and
needs to be repaired (75). Failure to repair the damage can lead to the mother cell passing
on mutations to its daughter cells which can have catastrophic consequences (75).
Tax was first linked to the DNA repair pathway when it was shown that it
represses the transcription of the human DNA polymerase p (pol (3) promoter (93), an
enzyme involved in base excision repair (BER) and mismatch repair (MMR) (94). Tax is
also able to suppress nucleotide excision repair (NER) (95), correlating with its ability to
activate the transcription of the proliferating cell nuclear antigen (PNCA) (96, 97). In
addition, Tax also interferes with the non-homologous end-joining (NHEJ) repair
pathway which is crucial in the repair of DNA double strand breaks (DSB) (98). DNA
double strand breaks (DSB) are one the most hazardous types of damage because they
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can cause genome rearrangement (173). Our laboratory previously showed that Tax
dysregulates the DSB repair pathway by directly interacting with DNA-PK (98) and
Chk2 (92). In addition to binding DNA-PK, Tax induces its hyperphosphorylation at
S2056 and T2609, thus activating it. This, in turn, leads to an increase in y-H2AX (98). It
was hypothesized that constitutive H2AX phosphorylation in Tax expressing cells was
interfering with the DNA damage repair machinery by not allowing the cell to detect and
repair newly formed damage (98, 105, 106).
Previously, we identified MDC1 as part of the Tax interactome using LC-MS/MS.
MDC1 is essential in the repair of DSB. Following DNA damage, activated MDC1 binds
to the phosphorylated serine 139 of H2AX, and in turn recruits the RJNG-fmger ubiquitin
ligase RNF8 to the IRIF. Next, RNF8 ubiquitylates y-H2AX, thus leading to a change in
chromatin conformation and allowing the recruitment of more DDR proteins (109). The
central role of MDC1 is illustrated by the fact that MDC1 -/- mice demonstrate many
phenotypes of H2AX -/- mice, including growth retardation, male infertility, immune
defects, chromosome instability, DNA repair and radiation sensitivity (113).
In the current study, we first confirmed the interaction between the HTLV-1
oncoprotein Tax and MDC1 using pull down and immunoblotting assays. Furthermore,
several Tax binding proteins are known to colocalize with Tax in the TSS (92, 98).
Therefore, we decided to investigate using immunohistochemistry the localization of
MDC1 in Tax expressing cells. We determined that Tax does indeed colocalize with
MDC1. Taken together, these results show that Tax binds MDC1 and recruits it to the
TSS. This correlates with the presence of phosphorylated DNA-PK hyperphosphorylation
at S2056 and T2609 in the TSS (98). Furthermore, Tax alters cellular pathways by either
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directly binding proteins involved in those pathways or by fr-ara-activating transcription
of cellular genes (62-66). Therefore, we looked at the total expression level of MDC1 in
Tax-expressing cells. The total amount of MDC1 did not change suggesting that Tax does
not activate or repress MDC1 expression.
MDC1 was also reported to increase in the chromatin fraction after DNA damage
(169) and we made the same observation in Tax expressing cells. Furthermore, using
siRNA experiment we found evidence that MDC1 activity is increased in Tax-expressing
cells. An increase in mono-ub-y-H2AX in the presence of Tax suggests that MDC1 is
active. This was further confirmed by the decrease in mono-ub-y-H2AX seen after MDC1
knock down in Tax expressing cells.
Finally, we also attempted to do a phosphopeptide mapping of MDC1 and found
that is was phosphorylated at several sites in the presence of Tax alone, including a site
that was reported to be phosphorylated following ionizing radiation. This result is another
indication that MDC1 is active in the presence of Tax. In the future, a comprehensive
phosphopeptide mapping can be done by using different approaches. For example
targeted MRM targeted analyses of tryptic peptides from the protein. The stoichiometry
between phosphorylated and non-phosphorylated peptides is usually low but this can be
overcome by using phosphopeptide specific affinity purification strategies, for example
IMAC (immobilized metal affinity chromatography) using gallium beads, titanium
T_i_

dioxide, and Fe to enrich the phosphopeptide before MS analysis.
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SECTION 5
DETERMINE THE FUNCTIONAL SIGNIFICANCE OF THE INTERACTION
OFTAXANDMDC1

Introduction
The transforming retrovirus human T-cell leukemia virus type 1 (HTLV-1) is the
etiological

agent

of

adult

T-cell

leukemia

(ATL)

and

HTLV-1

associated

myelopathy/tropical spastic paraparesis (HAM/TSP) (19, 34). The HLTV-1 Tax protein
plays a central role in viral transcription and cellular transformation (20, 37, 114, 120,
121). The oncogenic potential of Tax is illustrated by the fact that its expression can
alone cause cellular transformation (114). Tax binds and interferes with several proteins
involved in cell cycle and DNA damage repair. This is thought to be a major cause of the
Tax induced genomic instability, which ultimately leads to oncogenesis (75, 84, 92, 114,
174, 175).
A previous study from our laboratory determined that Tax interacts with DNAdependent Protein Kinase (DNA-PK), a protein involved in the repair of DNA double
strand breaks (DSB) (98). In addition, it was shown that Tax induces the phosphorylation
of DNA-PK at Ser-2056 (DNA-PK pS2056) and Thr-2609 (DNAP-PK pT2609)
suggesting that DNA-PK is active. This was further confirmed by an in vitro kinase assay
which showed an increased DNA-PK activity in the presence of Tax (98). Activation of
DNA-PK in Tax expressing cells leads to the phosphorylation of the histone protein
H2AX (termed y-H2AX) (98). In a normal cell, y-H2AX is considered as an early marker
of DNA damage. In addition, we have shown in this work that Tax binds and induces the
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activation of another DNA damage repair (DDR) protein called the mediator of DNA
damage checkpoint 1 (MDC1). MDC1 regulates various aspects of DNA damage
response pathways such as DNA-PK auto-phosphorylation (111) and the Chk2-mediated
DNA damage responses (112). MDC1 also binds y-H2AX at the phosphorylated serine
139 and recruits RNF8, a RING-finger ubiquitin ligase, which in turn ubiquitylates
H2AX. This induces a change in chromatin conformation causing the DNA to "open up",
thus allowing the recruitment of downstream DDR proteins (109, 110). Taken together,
these results showed that Tax binds and activates several proteins involved in the DNA
damage repair pathway.
Previous studies have shown that Tax forms discrete nuclear foci termed "Tax
speckled structures" (TSS) (68, 115). TSS overlap with interchromatin granules and
contain various proteins such as transcription factor

NF-KB

(115), and spliceosome

component 35 (SC35) (68, 115). Our laboratory also determined that Tax recruits several
DDR to the TSS, including phosphorylated DNA-PK at Ser-2056 and Thr-2609 (98) and
MDC1. In a normal cell, following DNA damage, DDR proteins get recruited to the
DNA damage sites called ionizing radiation-induced nuclear foci (IRIF) (104). Our
findings show a lot of similarities between IRIF and TSS. There are two possible
explanations for this resemblance. The first hypothesis is that Tax causes DNA damage
thus inducing the recruitment of DDR in the TSS. The second possibility is that Tax
causes aberrant activation of DDR proteins at the TSS in the absence of DNA damage,
which could lead to the dysregulation of the DNA damage repair machinery. To answer
this question, we needed to determine whether there is an increase in DNA damage in
Tax-expressing cells. Several DDR proteins such as y-H2AX have been used to detect
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newly formed DNA damage. However, in this study, due to the similarities between TSS
and IRIF, it was crucial to use an assay that directly detects the DNA breaks rather than a
protein involved in the signaling of the repair.
Here, we hypothesized that the impairment of the DNA damage repair machinery
by Tax does not allow the cell to detect and repair newly formed DNA damage.
Therefore, we also designed experiments in which we looked at DDR proteins in the
presence of both Tax and DNA damage. In addition, our laboratory previously generated
a Tax deletion mutant which corresponds the to minimum sequence requirement to be
targeted to the TSS. It was determined that the mutant had both the Nuclear localization
signaling (NLS) as well as the Tax TSS localization signal (TSS) (69). Therefore, we
attempted to test the mutant's ability to recruit DDR to the TSS. Finally, we sought to
assess the role of MDC1 in TSS formation. To do so, we used a MDC1 knock out cell
line and determined whether it had any effect on the TSS and the recruitment of other
DDR proteins.
The objective of this aim is to determine the role of MDC1 in the Tax induced
genomic instability. We will accomplish this objective using the following experimental
approaches. (1) We will measure DNA damage in Tax expressing cells in the presence
and absence of ionizing radiations using a BrdU assay; (2) We will use
immunohistochemistry techniques to determine the effect of both Tax and IR on the
localization MDC1 and other DDR proteins in the cell; (3) We will express a Tax
deletion mutant which corresponds to the minimum sequence requirement to be targeted
to the TSS and determine if it is sufficient to recruit DDR proteins; (4) We will use a
MDC1 knockout cell line and determine the role of MDC1 in TSS formation.
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Experimental Procedures
Cell culture and transient transfection
293 T cells were maintained at 37°C in a humidified atmosphere of 5% CO2 in air,
in Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine serum
(Cambrex, East Rutherford, NJ) and 1% penicillin-streptomycin (Invitrogen, Carlsbad,
CA).
Transfections of 293 T cells were performed by standard calcium phosphate
precipitation. Cells were plated at lxl0 5 cells/ml. The following day, plasmid DNA in
2M CaCb and 2X HBS were added dropwise to cells in fresh medium. Cells were
incubated at 37°C overnight and fresh medium was added. The cells were harvested 48 h
post-transfection, following a single wash with IX PBS, in 500 ul M-Per mammalian
protein extraction reagent (Pierce, Rockford, IL) with protease inhibitor cocktail (Roche,
Palo Alto, CA) and immediately frozen at -80°C.
Mouse embryonic fibroblast MDC1 knockout cells were a gift from Dr. Lou,
Mayo Clinic, Rochester, MN. The cells were maintained at 37°C in a humidified
atmosphere of 5% CO2 in air, in Dulbecco's modified Eagle medium supplemented with
10% fetal bovine serum (Cambrex, East Rutherford, NJ) and 1% penicillin-streptomycin
(Invitrogen, Carlsbad, CA). For transient transfection, cells were plated on coverslip at
lxl0 5 cells/ml in 6 well plates and left to grow overnight. The following day medium was
changed with serum free and antibiotic free media 1 hour prior to transfection. A total of
6 \ig of STaxGFP was diluted in 250 ul of Opti-MEM® I medium without serum. Next,
Lipofectamine™ 2000 was gently mixed then 5 ul was diluted in 250 ul of Opti-MEM® I
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medium without serum in a separate tube. The mixture was mixed gently and incubated
for 5 minutes at room temperature. After 5 minutes incubation, the diluted DNA was
mixed with the diluted Lipofectamine™ 2000. The solution was mixed gently and
incubated for 20 minutes at room temperature to allow complex formation to occur. The
DNA-Lipofectamine™ 2000 complexes were then added to the plate. We then mixed
gently by rocking the plate back and forth. We incubated the cells at 37°C in a CO2
incubator for 6 hours. The media was replaced with media that had serum and antibiotic.
Cells were left to grow for 48 hours.

Plasmids
Generation of the STaxGFP, STax and SGFP plasmids have been described
earlier (144). Briefly, the S-tagged expression vectors STaxGFP, STax and SGFP were
constructed by inserting the tax-EGFP fusion or EGFP ORF, respectively, into the Smal
site of pTHEx4-Neo (Novagen, Madison, WI) in frame with the amino-terminal S-tag and
His-tag.

Br dU Assay
Mock transfected and STaxGFP transfected cells were labeled with 10 ng/ml of
5' bromo 2' deoxyuridine (BrdU, Sigma, St. louis , MO) for 30 h, then treated with 15 Gy
of X-rays or left untreated. After ionizing radiation, cells were left to grow for 16 hours,
fixed with methanol for 5 minutes at -20°C and blocked with 3% BSA for 30 minutes.
Cells were immunolabelled with anti BrdU followed by anti mouse Alexa Fluor 594-
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conjugated secondary antibody (Molecular Probes). Nuclei were counterstained with ToPro-3 iodide (Molecular Probes) diluted at 1/1,000.

Immunoblot analysis
Proteins separated by electrophoresis were transferred

to Immobilon-P

membranes (Millipore, Billerica, MA) using the semidry transfer method with 20 V
applied for 1 hour. The membranes were then blocked for 1 hour at room temperature in
IX Odyssey blocking buffer (Li-Cor Biosciences, Lincoln, NE). Primary antibodies
diluted in lx Odyssey blocking buffer were applied to the membranes and allowed to
interact at 4°C overnight on an orbital shaker. Membranes were washed four times for 5
minutes with PBS-1% Tween. Li-Cor Odyssey secondary antibodies were diluted to a
concentration of 1/20,000 in lx Odyssey blocking buffer containing 0.5% SDS and 0.5%
Tween and then incubated for 1 hour at room temperature on an orbital shaker in the dark.
The membranes were washed four times for 5 minutes with PBS-1% Tween and then
stored in PBS and in the dark until ready to be analyzed. Blots were scanned and
analyzed with a Li-Cor Odyssey scanner and software (Li-Cor Biosciences, Lincoln, NE).

Immunofluorescence
Cells were plated on a coverslip and treated with 10 Gy of X-rays or left
untreated. After 4 hours, cells were washed twice with ice-cold PBS. Cells were then
fixed with 4% paraformaldehyde for 12 minutes at room temperature. Next, cells were
washed 3 times with PBS. Methanol was added and left on the cells for 2 minutes. Cells
were washed 4 times with PBS. The primary antibody was diluted in 3% bovine serum
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albumin (BSA) in PBS at the appropriate concentration. A 100 ul drop of the diluted
primary antibody was then placed on parafilm in a wet chamber. The coverslip was then
inverted onto the drop and left incubating at 4°C overnight. The next day, the coverslip
was removed from the parafilm and placed back into the tissue culture dish. The cells
were washed twice with PBS-1% Tween 20 and twice with PBS. The species-appropriate
Alexa Fluor 594-conjugated secondary antibody (Molecular Probes) was diluted at
1/1000 in 3% BSA in PBS. Nuclei were counterstained with To-Pro-3 iodide (Molecular
Probes) diluted 1/1,000 in the same BSA-PBS and secondary antibody solution. A 100 ul
drop of BSA-PBS solution containing both the secondary antibody and To-Pro-3 was
placed onto parafilm in a wet chamber. The coverslip was inverted onto the drop and left
incubating for 1 hour at room temperature in the dark. Next, the coverslip was put back
into a tissue culture dish and washed twice with 3% BSA in PBS then twice with PBS.
One drop of Vectashield mounting medium with DAPI (Vector Laboratories Inc,
Burlingame, CA) was placed onto a slide. The coverslip was inverted onto the slide and
left to air dry for one hour at room temperature in the dark. The coverslip was then sealed
to the slide using nail polish. Confocal fluorescent images were acquired using a Zeiss
LSM 510 confocal microscope at 63X magnification with a 2X zoom using Argon (488
ran), HeNel (543 nm), and HeNe2 (633 nm) lasers, and imaged with LSM Image
Browser software (Carl Zeiss, Jena, Germany).

Antibodies
For immunofluorescence analysis, we used the following antibodies: anti-MDCl
goat polyclonal (1/100, Santa Cruz Biotechnology, Santa Cruz, CA), anti-BrdU mouse
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monoclonal (1/50, BD Biosciences, San Jose, CA), anti-BRCAl mouse monoclonal
(1/100, Santa Cruz Biotechnology, Santa Cruz, CA), anti-NBSl rabbit polyclonal (1/400,
Novus Biologicals, Littleton, CO), anti-DNA-PK pT2609 mouse monoclonal (1/400,
Abeam, Cambridge, MA).

Results
Tax does not induce DNA breaks
Compelling data from our laboratory suggests that Tax activates and recruits
several DDR proteins to the TSSs such as DNA-PK (98), Chk2 (92) and MDC1. In other
words, TSS seem to mimic IRIF. Therefore, we attempted to determine whether the
recruitment of DDR proteins to the TSS is the result of actual DNA damage. To do so,
we needed to use an assay that can directly detect the DNA breaks. Therefore, we used a
BrdU staining protocol that allows the visualization of single-stranded DNA breaks after
ionizing radiation (IR) (176). Briefly, Tax expressing cells were pulsed with BrdU for 30
hours before ionizing radiation treatment, to completely label the DNA. No denaturation
step was used before anti-BrdU staining, therefore the only accessible BrdU epitopes
occur at sites of single-stranded DNA breaks (SSBs). Ionizing radiation mainly causes
DSBs, but as the damage sites are being repaired, DNA DSBs are processed into single
stranded DNA (ssDNA) (176, 177). If TSS are in fact sites of DNA damage and DDR
proteins are recruited to these sites then these damage sites should be getting repaired.
Thus at least some of them, if not all, should be converted to ssDNA. The BrdU
experiment was conducted in Tax expressing cells in the absence of DNA damage, and
our data show that the TSS are not sites of DNA damage since they did not stain for
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BrdU (Fig. 20A). This result supports the idea that Tax recruits several DDR proteins to
the TSS such as Chk2 (92), DNA-PK (98) and MDC1 and aberrantly activates them.
Ultimately, this may lead to the dysregulation of DNA damage repair pathway.

IRIF and TSS are distinct structures
The same BrdU assay was also conducted on Tax expressing cells treated with IR.
This allowed us to determine the location of the TSS relative to the IRIF. The majority of
IRIF do not colocalize with the TSS following IR (Fig. 20A). In addition, we counted the
number of DNA damage sites in cells that express and do not express Tax before and
after IR (Fig. 205). We found that the average number of foci is generally the same
regardless of the presence or absence of Tax. This result shows that Tax does not induce
an increase in DNA damage following IR.

Characterization of the IRIF and the TSS
We determined that the TSS and IRIF are distinct from each other. We also
showed that Tax does not induce an increase in IRIF when cells are treated with IR. Still,
the dysregulation of the DNA damage repair machinery via the recruitment of DDR
proteins to the TSS seem to be a crucial mechanism by which Tax induces genomic
instability. Next, we investigated the effect of IR on MDC1 and phosphorylated DNA-PK
localization in Tax expressing cells (Fig. 21). Immunofluorescence analysis showed that
DNA-PK pT2609 is located in both IRIF and TSS following IR. On the other hand,
MDC1 seems to leave the TSS and is relocalized to the IRIF. This suggests that there is a
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FIGURE 20. Tax does not induce DNA breaks. A, STaxGFP was expressed
in 293 T cells and the cells were pulsed with BrdU for 30 hours. When
indicated, cells were treated with ionizing radiation and fixed with methanol 16
hours post-Ionizing radiation. BrdU was detected with the indicated antibody.
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magnified x63 with a x4 zoom.
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limited amount of MDC1 in the nucleus and that it is competed for between TSS and
IRIF. DNA-PK levels may be high enough in the cells so that it is sufficient to be present
in both TSS and IRIF. This finding demonstrates that MDC1, contrary to DNA-PK, is a
limiting factor and that the competition for MDC1 between TSS and IRIF may play a role
in the dysregulation the DNA damage machinery by Tax.
In addition, we decided to further characterize the IRIF and the TSS by looking at
DDR proteins that were not previously known to colocalize with Tax. BRCA1 is a DDR
protein that interacts indirectly with Rad51 (178) and directly with SWI/SNF (179) which
are both known to bind Tax (130). A colocalization study of BRCA1 determined that this
protein follows the same pattern as pT 2609-DNA-PK (Fig. 21). In other words, in the
absence of DNA damage, it is present in the TSS and following IR it is located in both
the TSS and IRIF, suggesting TSS and IRF do not compete for BRCA1. Another DDR
protein that we investigated is NBS1 which is part of the MRE11-RAD50-NBS1 (MRN)
complex. This complex is crucial for DNA damage repair and it is recruited to the DNA
damage site by MDC1 via the binding of the phosphorylated Ser-Asp-Thr (SDT) repeats
of MDC1 to the N-terminal FHA domain of NBS1 (162, 163). Interestingly,
immunofluorescence analysis shows that NBS1 is not present in the TSS (Fig. 21). This
result suggests that when present in the TSS, MDC1 is unable to recruit NBS1. More
importantly, this also highlights a significant difference between TSS and IRIF,
demonstrating that even though these two entities are similar, they are not identical.
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Tax protein bridges the recruitment of DDR proteins to the TSS
Tax is present in both the nucleus and the cytoplasm and needs to be targeted to
the TSS. Our laboratory determined that in addition to the nuclear localization signal
(NLS) that targets Tax to the nucleus, there is a TSS localization signal (TSLS) that is
needed for Tax to be directed to the TSS (69). The TSLS was mapped to a region
containing amino acids 50 to 75 (Fig. 22A). The NLS is adjacent to the TSLS and is
between amino acid 18 and 52 (69, 180). In that same study, it was determined that the
minimum sequence requirement for the targeting of Tax to the TSS was from amino acid
1-75 (69). Here, we investigated whether targeting Tax to the TSS is sufficient for the
recruitment of DRR proteins. Our results shows that the Tax mutant does not colocalize
with DNA-PK pT2609 and MDC1 (Fig. 225), demonstrating that the 1-75 region is
responsible for the targeting and that the rest of the protein, from amino acid 75 to 353, is
required for the recruitment and activation of DDR proteins. This result suggests that Tax
bridges the recruitment process.

MDC1 is not requiredfor TSS formation
In order to investigate the role of MDC1 in the formation of TSS, we used MDC1
mouse embryonic fibroblast (MEF) knockout cells. Alternatively, we could have used
siRNA technique to knockdown MDC1. However, this technique would leave a small
amount of MDC1 in some cells which might still be sufficient for proper TSS formation.
The use of MDC1 knockout cell lines insures the total absence of MDC1 in all the cells.
In other words, if we can see TSS in MDC1 knockout cells, it would mean that Tax does
not require MDC1 to form the TSS. Results from our immunofluorescence studies

88

NF-KB activating

Zinc-Finger
/

\

CREB

50

P/CAF

^\

Dimerization domain

SH3

"> n r~
fcslslWmM

NLS
I

t

100

150

PDZ

n

~>

H 1 H 1
200

250

l>Ae¥
300

353

I ' I I ' I ' ' I I I ' I I I I I ' I I I I I I I I I I I I I I'

B
Merged+TO-PRO

NoIR

Merged-"-TO-PRO

IR

Merged+TO-PRO

NoIR

M e r g e d * TO-PRO

IR
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89

showed that TSS could efficiently form in the MDC1 knockout cells (Fig. 23). This
suggests that TSS first form, next MDC1 is recruited and activated.

Discussion
Tax is known to interact and interfere with several DDR proteins. These
interactions are though to be a major cause of the Tax induced genomic instability, which
ultimately leads to oncogenesis (75, 84, 92, 114, 174, 175). Our laboratory showed the
interaction of Tax with the DDR protein MDC1. MDC1 regulates various aspects of
DNA damage response pathways (109-112). Interestingly, it seems that Tax not only
recruits MDC1 and other DDR proteins to the TSS but it also induces their activation (98,
146). These data suggested that TSS might mimic IRIF. To investigate this hypothesis,
we attempted to further characterize these two entities.
Here, we demonstrated that, contrary to IRIF, TSS are not sites of DNA damage.
This result allows us to clearly distinguish between TSS and IRIF. In addition, we saw
that following IR treatment, the DNA damage sites were localized away from the TSS.
This correlates with our immunofluorescence studies when looking at the localization of
different DDR proteins. In fact, following IR, some DDR proteins such as MDC1 seem to
be relocalized from the TSS to the IRIF. On the other hand, other DDR proteins like
DNA-PK pT2609 and BRCA1 are located in both TSS and IRIF. We hypothesized that
this difference might be due to the level of each protein in the cell. DNA-PK and BRCA1
may be abundant enough that they can be recruited to both the IRIF and TSS. However,
levels of MDC1 in the cell, which we have previously shown to not change in the
presence of Tax, might be too low for MDC1 to be recruited to both TSS and IRIF.
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FIGURE 23. Tax is able to form TSS in MDC1 knockout cells. STaxGFP
was expressed in MEF MDC1 -/- cells. Tax expression was detected via the
GFP fusion. Nuclei were visualized by co-staining with TO-PRO-3 iodide.
Confocal microscopy images are magnified x63 with a x4 zoom.
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Therefore, MDC1 may be a limiting factor in the competition between IRIF and TSS for
DDR proteins. This competition could result in the dysregulation of the DNA damage
repair pathway thus leading to Tax induced genomic instability. In addition, we found
that NBS1 is not present in the TSS. This showed a significance difference between TSS
and IRIF demonstrating that even though they are similar, they are not identical. Finally,
we determined that TSS can be formed in MDC1 knockout cell line, thus suggesting that
the chronological arrangement of the complex involves first the formation of the TSS
followed by the recruitment of MDC1. Next, we investigated the ability of TSS to recruit
DDR proteins using a Tax mutant that has the minimum sequence requirement for
targeting it to the TSS (Tax 1-75). Our results showed that even though Taxi-75 is able
to form TSS, it is unable to recruit DDR proteins. This suggests that the region of Tax
responsible for the recruitment of DDR proteins is different from the one responsible for
its targeting to the TSS.
Our laboratory previously showed that Tax increases DNA-PK's activity, thus
leading to an increase in y-H2AX (98). It was hypothesized that constitutive H2AX
phosphorylation in Tax expressing cells was interfering with the DNA damage repair
machinery by not allowing the cell to detect and repair newly formed damage (98, 105,
106). In light of our results in this study, we can extend our model further. In our model
of Tax induced genomic instability, Tax is targeted to the TSS via its 1-75 amino acid
region. Next, it recruits and aberrantly activates several DDR proteins such MDC1,
DNA-PK pT2609 via the 75-353 region. When DNA damage occurs in Tax expressing
cells, DDR proteins need to be recruited to the IRIF in order to repair the newly formed
DNA breaks. Some proteins such as DNA-PK may be abundant enough to be present in
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both the TSS and IRIF. Others, such as MDC1, may only be available at a limited amount
thus creating a competition between IRIF and TSS. In some cases, MDC1 may not be
properly recruited to the IRIF, which could cause an improper formation of the DNA
damage repair complex. Ultimately, this might initiate an inappropriate repair of the
damage leading to mutations and genomic instability.
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SECTION 6
CONCLUSIONS

Summary
In this study, we have engineered an assay in which we isolated the Tax
interactome and studied it using mass spectrometry. We have found many known Tax
binding proteins and some novel ones. One of the new Tax interacting proteins is MDC1,
a DNA damage repair protein. Tax is known to interfere with the DNA damage repair
pathway; therefore we decided to focus on its interaction with MDC1. Pull down
experiments confirmed the interaction between MDC1 and Tax, and a siRNA study
determined

that

MDC1

is

active

in

Tax

expressing

cells.

In

addition,

immunofluorescence analysis showed that MDC1 is present in the TSS. This correlates
with a study previously done by our laboratory that showed that DNA-PK pT2609 is also
present in the TSS.
Our data indicated that the TSS and IRIF share a lot of similarities. Therefore, we
decided to further characterize these two complexes. First, we determined that TSS are
not sites of DNA breaks which clearly distinguish them from IRIF. Secondly, we looked
at the different DDR proteins and their localization in Tax expressing cells before and
after ionizing radiation (IR). BRCA1, MDC1 and DNA-PK pT2609 were all present in
the TSS, but NBS1, another DDR proteins associated with IRIF, was not found in the
TSS. Due to the central role of NBS1 in the DNA damage repair pathway, this result
highlighted a striking difference between TSS and IRIF. In addition, following IR
treatment, DNA-PK pT2609 and BRCA1 were present in both TSS and IRIF whereas
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MDC1 seemed to be relocalized from the TSS to the IRIF. We hypothesized that there
might be a competition between IRIF and TSS for MDC1 which could be available only
in a limited amount in the cell. Finally, we investigated the mechanism by which Tax and
the DDR are recruited to the TSS. We determined that the presence of MDC1 is not
necessary for the formation of the TSS, suggesting that Tax is first recruited to the TSS
which then leads to the recruitment of the different DDR proteins. In addition, we showed
that the sequence responsible for the targeting of Tax to the TSS is not sufficient for the
recruitment of the DNA-PK pT2609 and MDC1, suggesting that the rest of the Tax
sequence is responsible for the recruitment of the several DDR proteins found in the TSS.
Taken these results together, we formulated a model of Tax induced genomic
instability (Fig. 24). In our model, Tax gets recruited to the TSS via its 1-75 region. Next,
Tax recruits several DDR proteins. When DNA damage occurs, DDR proteins need to be
recruited to the IRIF in order to repair the DNA breaks. This leads to a competition
between the IRIF and TSS. Tax may be able to prevent some DDR proteins, such as
MDC1, to be recruited to the IRIF which could lead to inappropriate repair of DNA
breaks. This could induce an accumulation of mutations and ultimately cause genomic
instability.

Significance of Findings
Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus that infects 20
million people worldwide (20). It is endemic in southwestern Japan, Africa, the
Caribbean islands and South America.

In Japan alone, there are approximately 1.2

million infected individuals (20). The main modes of transmission are from mother to
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infant via breastfeeding, sexual contact and parenteral transmission (181). It was the first
retrovirus to be shown to cause a human cancer, adult T-cell leukemia (ATL) (19). In
addition, it can also induce another incurable life threatening disease called HTLV-1 associated myelopathy and tropical spastic parapesis (HAM/TSP) (34). Soon after
infection the virus goes into a latent state, making the infected individuals asymptomatic
seropositive carriers. About 5% of these individuals develop one of the viral associated
diseases 10 to 40 years after infection (37). In Japan, 800 to 1000 new ATL cases are
diagnosed every year (20). ATL is an extremely aggressive disease with a poor
prognosis, and it is also resistant to chemotherapeutic treatment (38). Study of the
molecular pathogenesis of HTLV-1-mediated T-cell transformation is crucial to improve
ATL treatment. The viral Tax protein is considered to play a central role in the process
leading to ATL (37). It is thought that Tax causes transformation through various
mechanisms that are not yet fully understood such as chromosomal instability and the
abrogation of DNA repair (20).
Tax is known to interact with a wide variety of cellular proteins and it is believed
that it may interfere with their functions (67). In this study, we successfully isolated the
Tax interactome and analyzed it using mass spectrometry. This study adds a tremendous
amount of knowledge to the proteins already known to bind Tax. In addition, with this
assay we detected several known Tax binding proteins thus confirming the fidelity of our
approach. We were also able to find several new Tax binding proteins that are involved in
various pathways that are known to be affected by Tax. Results from this experiment are
therefore a good starting point for the study of these proteins in relation to Tax. In
addition, we confirmed that MDC1, which is a novel Tax interacting protein found in our
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mass spectrometry data, did in fact interact with Tax thus highlighting the efficiency of
our assay in identifying new Tax binding patterns.
In addition, we further investigated the relationship between TSS and IRIF. To
our knowledge, our study is the first one that clearly shows that TSS are not sites of DNA
breaks. This finding is significant because just like IRIF, which are sites of DNA breaks,
TSS recruits several DDR proteins. This similarity could lead to the assumption that TSS
recruits DDR proteins because they are also site of DNA breaks that need to be repaired.
Here, we show that that assumption is false. Another important contribution to the field
that was made is the introduction of a novel model of Tax induced genomic instability,
thus giving us a better understanding of HTLV-1 -mediated T-cell transformation. In our
model, there is a competition between IRIF and TSS for DDR proteins which could lead
to improper repair of some damaged DNA. In vivo, Tax levels are low and the amounts of
DNA damage experienced by cells are also much lower to what we see in our
experimental model. In other words, the competition between the TSS and IRIF in vivo is
much more discrete which would explain the low level of HTLV-1 infected patients that
develop ATL and the long time of onset of the disease.
Our model correlates with the findings of an earlier study that showed that, in
HTLV-1 infected cells, MDC1 and y-H2AX did not colocalize after IR, suggesting that
Tax may interfere with the recruitment of MDC1 to the DNA damage sites (182). Our
findings give a potential mechanism to would explain this phenomenon.

Future Directions
The experimental model used to identify Tax interacting proteins is a valuable
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tool to study other novel Tax binding proteins. Using mass spectrometry, we already
identified several proteins that we think should be studied further. One example of such
protein is the interferon gamma-inducible protein 16 (IFI-16). IFI-16 is involved in p53
dependent apoptosis (149). The tumor suppressor p53 protein is involved in several
cellular pathways such as cell cycle (183), apoptosis (184, 185) and DNA repair (186). It
has been shown that the loss of IFI-16 causes the dysregulation of p53 mediated
apoptosis, leading to cellular transformation (149). In addition, Tax is known to interfere
with p53 function. It is believed that Tax inactivates it thus inhibiting apoptosis. The
mechanism by which this happens is not yet fully understood, but it has been determined
that the two proteins do not to interact directly (187-191). Therefore, the binding of Tax
to IFI-16 could play a role in Tax-induced p53 inactivation. We can speculate that Tax
might be sequestering IFI-16 from p53 thus interfering with its function. This hypothesis
should be further investigated by first confirming the binding of Tax to IFI-16.
Another protein identified using mass spectrometry is the minichromosome
maintenance deficient protein 7 (MCM7). This protein is implicated in DNA replication
(150). Tax expressing cells exhibit an increase in DNA replication which combined with
an enhancement of cell cycle progression contribute to cellular transformation (192-197).
One proposed mechanism is that Tax trans-activates PCNA which enables the cell to
bypass the p21-dependent in DNA replication in the presence of DNA damage (97, 197).
The interaction with MCM7 could be another way by which Tax enhances DNA
replication.
Studies that further characterize the relationship between DDR proteins and Tax
should also be pursued. A recent study showed that the activation of DDR does not

99

require DNA damage (198). In that study, DDR proteins were fused to the E. coli lacrepressor (lacR) and tagged with Cherry-Red fluorescent protein. The fusion proteins
were introduced into a NIH-3T3 cell line which contains 256 repeats of the lac operator
sequence (lacO) stably integrated on chromosome 3. This causes the fusion proteins to
accumulate at the lacO array as distinct nuclear foci. Interestingly, the stable association
of single repair factors to the chromatin was sufficient for the activation of the DNA
damage repair pathway. For instance, when LacR-MDCl-Cherry was expressed, it was
targeted to chromatin and formed a distinct nuclear focus. After staining for y-H2AX, it
was shown that a y-H2AX focus also formed and that it colocalized with LacR-MDClCherry. This result suggests that the DNA damage repair pathway can be activated by
just targeting MDC1 to the chromatin. Our laboratory recently received the LacR-MDClCherry vector as well as the NIH-3T3 cell line and we were able to successfully
reproduce the same results (data not shown). In a future study, we will clone a Tax
mutant that lacks the TSLS and NLS sequence into the LacR-Cherry vector. Introduction
of that plasmid should target Tax to the chromatin and we should investigate its ability to
recruit DDR proteins. This experiment would allow us to confirm that Tax recruits DDR
proteins in the absence of DNA damage.
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APPENDIX A
LIST OF THE 76 PROTEINS FOUND IN THE TAX INTERACTOME

Identified proteins
60 kDa heat shock protein, mitochondrial precursor- Homo sapiens (Human)
DNA-dependent protein kinase catalytic subunit - Homo sapiens (Human)
Vimentin - Homo sapiens (Human)
Tubulin beta-2C chain - Homo sapiens (Human)
Gamma-interferon-inducible protein lfi-16 - Homo sapiens (Human)
Tubulin alpha-4A chain - Homo sapiens (Human)
ATP-dependent RNA helicase A - Homo sapiens (Human)
Stress-70 protein, mitochondrial precursor - Homo sapiens (Human)
Heterogeneous nuclear ribonucleoprotein A1 - Homo sapiens (Human)
Heat shock protein HSP 90-alpha - Homo sapiens (Human)
Lamina-associated polypeptide 2 isoform alpha - Homo sapiens (Human)
DNA topoisomerase 2-alpha - Homo sapiens (Human)
Core histone macro-H2A.1 - Homo sapiens (Human)
Matrin-3 - Homo sapiens (Human)
GMP synthase [glutamine-hydrolyzing] - Homo sapiens (Human)
DNA replication licensing factor MCM7 - Homo sapiens (Human)
Heterogeneous nuclear ribonucleoprotein R - Homo sapiens (Human)
F-box only protein 22 - Homo sapiens (Human)
Heterogeneous nuclear ribonucleoproteins C1/C2 - Homo sapiens (Human)
ATP-dependent DNA helicase 2 subunit 1 - Homo sapiens (Human)
Heterogeneous nuclear ribonucleoprotein H - Homo sapiens (Human)
Splicing factor, proline- and glutamine-rich - Homo sapiens (Human)
Heat shock 70 kDa protein 6 - Homo sapiens (Human)
Heterogeneous nuclear ribonucleoprotein A3 - Homo sapiens (Human)
60S acidic ribosomal protein P2 - Homo sapiens (Human)
Lymphoid enhancer-binding factor 1 - Homo sapiens (Human)
Histone H2A type 2-A - Homo sapiens (Human)
Far upstream element-binding protein 2 - Homo sapiens (Human)
Nucleolar protein 5A - Homo sapiens (Human)
Stomatin-like protein 2 - Homo sapiens (Human)
Histone H2AV - Homo sapiens (Human)
78 kDa glucose-regulated protein precursor - Homo sapiens (Human)
Peptidyl-prolyl cis-trans isomerase A - Homo sapiens (Human)
Protein-L-isoaspartate(D-aspartate) O-methyltransferase - Homo sapiens (Human)
60S ribosomal protein L4 - Homo sapiens (Human)
ATP-dependent RNA helicase DDX3X - Homo sapiens (Human)
Protein Tax-1 - Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1)
Calnexin precursor - Homo sapiens (Human)
Replication protein A 70 kDa DNA-binding subunit - Homo sapiens (Human)
Splicing factor 3B subunit 1 - Homo sapiens (Human)
Mediator of DNA damage checkpoint protein 1 - Homo sapiens (Human)
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APPENDIX A, Continued

Identified proteins (continued)
Interleukin enhancer-binding factor 3 - Homo sapiens (Human)
Cell division control protein 2 homolog - Homo sapiens (Human)
Prolow-density lipoprotein receptor-related protein 1 precursor - Homo sapiens (Human)
Histone H3.1 - Homo sapiens (Human)
Myosin-11 - Homo sapiens (Human)
Probable global transcription activator SNF2L4 - Homo sapiens (Human)
Histone-binding protein RBBP4 - Homo sapiens (Human)
Splicing factor 3B subunit 2 - Homo sapiens (Human)
Annexin A2 - Homo sapiens (Human)
Poly(rC)-binding protein 1 - Homo sapiens (Human)
Far upstream element-binding protein 1 - Homo sapiens (Human)
40S ribosomal protein S15a - Homo sapiens (Human)
Single-stranded DNA-binding protein, mitochondrial precursor- Homo sapiens (Human)
ATP-dependent RNA helicase DDX18 - Homo sapiens (Human)
Spectrin beta chain, brain 1 - Homo sapiens (Human)
Tubulin gamma-1 chain - Homo sapiens (Human)
U5 small nuclear ribonucleoprotein 200 kDa helicase - Homo sapiens (Human)
Replication factor C subunit 4 - Homo sapiens (Human)
Delta-1-pyrroline-5-carboxylate synthetase - Homo sapiens (Human)
40S ribosomal protein S10 - Homo sapiens (Human)
N-acetyltransferase 10 - Homo sapiens (Human)
RNA-binding protein Raly - Homo sapiens (Human)
DNA ligase 3 - Homo sapiens (Human)
Nuclear pore complex protein Nup93 - Homo sapiens (Human)
Thioredoxin - Homo sapiens (Human)
T-complex protein 1 subunit beta - Homo sapiens (Human)
Cell growth-regulating nucleolar protein - Homo sapiens (Human)
Ran GTPase-activating protein 1 - Homo sapiens (Human)
PC4 and SFRS1-interacting protein - Homo sapiens (Human)
14-3-3 protein zeta/delta - Homo sapiens (Human)
T-complex protein 1 subunit gamma - Homo sapiens (Human)
Exportin-1 - Homo sapiens (Human)
RNA-binding protein 34 - Homo sapiens (Human)
Ras-related protein Rab-5C - Homo sapiens (Human)
Chromodomain-helicase-DNA-binding protein 7 - Homo sapiens (Human)
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